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ABSTRACT 
 Sarcopenia is defined as the progressive, age related loss of lean muscle mass, 
which in turn has been associated with osteoporosis, decreases in physical function, 
and loss of independence.  Newly established sarcopenia classification criteria include 
measures of appendicular lean mass (ALM), grip strength, and gait speed.  Periodized 
resistance training (PRT) has been investigated in older adults, however the impact of 
PRT, particularly daily undulating periodized resistance training (DUP) on current 
sarcopenia classification criteria is unknown.  The aim of this randomized controlled 
trial was to investigate the effects of a 10-week DUP intervention on sarcopenia 
classification in older women.  Inactive women (n=25) aged 72.3±4.6 years, who were 
sarcopenic or symptomatic, were randomized to a DUP group or an active control 
group (CON) and trained three days per week for 10 weeks.  Measures of ALM, grip 
strength, and gait speed were recorded at baseline and post-intervention and 
sarcopenia was classified using established criteria.  Other measures included upper 
and lower body strength, and global physical functioning.  A McNemar’s test found no 
significant within- or between-group changes in sarcopenia classification.  Mixed 
models analyses found both groups significantly improved gait speed (DUP: p=0.001, 
CON: p<0.001) but DUP significantly increased grip strength compared to CON 
(p=0.036).  There were no significant changes in ALM for either group.  Both groups 
significantly improved upper and lower body strength (p<0.001) and global physical 
function (DUP: p=0.039, CON: p=0.008).  Results indicate DUP increases strength 
and function, but does not significantly alter sarcopenia classification compared to 
  
CON.  However, results are limited by sample size and demonstrate the need for 
future research to investigate trials in larger samples with longer durations.  
 
 
 
 
 
 
 
 
 iv 
 
ACKNOWLEDGMENTS 
The generous funding for the URI Resistance Exercise Study to Reclaim Lean 
Mass and Strength (URI RESTORE ME) was provided by the College of Human 
Science and Services.  The study was conducted by the Department of Kinesiology 
and the Department of Nutrition and Food Sciences.  I would like to thank all of the 
primary investigators of the URI RESTORE ME study: Dr. Delmonico, Dr. Xu, Dr. 
Hatfield, and Dr. Lofgren.  I was fortunate enough to receive valuable guidance from 
these professors during my time as a graduate student.  I would also like to recognize 
Dr. Delmonico’s efforts as my primary advisor for my thesis.  His experience, 
guidance, feedback, and motivation made completing this thesis possible.  Also 
making this thesis possible was the hard work and dedication of my fellow study 
coordinators, Emily Renna and Kayla Mahoney.  I would also like to thank my parents 
for their support and assistance throughout this process.  Finally I would like to thank 
my girlfriend Geena for always supporting and motivating me over the past two years 
of graduate school.  The combined efforts of all of the above-mentioned individuals 
made completing this thesis and advancing the field of sarcopenia and resistance 
training research possible.  
 
 
 
  
 v 
 
PREFACE 
 This thesis is written to comply with the University of Rhode Island graduate 
school manuscript format.  The thesis document contains one manuscript:  Effects of 
10 Weeks of Periodized Resistance Training on Sarcopenia Classification in Older 
Women. The manuscript has been written in a form formatted for publication in the 
Journal of Aging and Physical Activity. 
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ABSTRACT 
Sarcopenia is associated with negative health outcomes in older adults, but research on 
the effects of resistance training on sarcopenia is lacking.  This study used a 
randomized trial to investigate the effects of daily undulating periodized resistance 
training (DUP) on sarcopenia classification.  Inactive women (n=25) aged 72.3±4.6 
years, who were sarcopenic or symptomatic, were randomized to a DUP group or an 
active control group (CON) and trained three days per week for 10 weeks.  No 
significant changes in sarcopenia classification were observed.  Both groups 
significantly improved physical functioning (DUP: p=0.039, CON: p=0.008) and 
strength (DUP and CON; p<0.001), but DUP significantly increased grip strength 
compared to CON (p=0.036).  Results indicate DUP increases strength and function, 
but does not significantly alter sarcopenia classification compared to CON.  However, 
results are limited by sample size and demonstrate the need for future research to 
investigate trials in larger samples with longer durations.  
 
Keywords: post-menopausal, daily undulating periodization, strength training, 
EWGSOP, FNIHSP 
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INTRODUCTION 
 The aging process contributes to multiple changes within the human body 
including muscle fiber atrophy, a loss of type 2 muscle fibers, and fatty infiltration of 
skeletal muscle (Alchin, 2014; Kostek & Delmonico, 2011).  Sarcopenia, known as 
the age-related loss of skeletal muscle mass, can negatively affect physical functioning 
and muscular strength.  Indeed, following age 50 years, muscle mass decreases ~1-2% 
per year and muscle strength decreases at rates 2 to 5 times faster than muscle mass.  
These decreases have been observed in both men and women of varying ethnicities 
(Batsis, Mackenzie, Barre, Lopez-Jimenez, & Bartels, 2014; Cawthon et al., 2011; 
Delmonico et al., 2009; Visser et al., 2005).  The atrophy of skeletal muscle fibers and 
subsequent loss of muscle mass that occur during the development of sarcopenia 
coupled with rapidly decreasing muscular strength places older individuals at risk for 
injury and/or disability (Yang, Ding, Luo, Hao, & Dong, 2014). 
 Furthermore, the estimated healthcare costs directly associated with sarcopenia 
in 2000 were $18.5 billion, with more than $7 billion attributed to older women 
(Janssen, Shepard, Katzmarzyk, & Roubenoff, 2004).  A greater percentage of the 
older population is female, and they are at a greater risk of developing sarcopenia 
because women live longer, typically have lower amounts of lean mass and lower 
physical activity levels in old age when compared to men (Administration on Aging, 
2014; Batsis et al., 2014; Borst, 2004; Chad et al., 2005; Douchi et al., 1998).  
Additionally, estimates indicate that there will be 80 million U.S. adults over the age 
of 65 by 2050, which is double the estimated 40 million adults in 2010 (US 
Department of Health & Human Services, 2006).  The already significant health care 
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costs, increased risk for older women and estimated population increases indicate that 
sarcopenia is a serious public health issue, and intervention strategies are necessary to 
attenuate the loss of physical functioning, lean mass and muscular strength in older 
women. 
 Current sarcopenia classification criteria have been established by the 
European Working Group on Sarcopenia in Older People (EWGSOP) (Cruz-Jentoft et 
al., 2010), the International Working Group (IWG) (Fielding et al., 2011), and the 
Foundation for the National Institutes of Health Sarcopenia Project (FNIHSP) 
(Studenski et al., 2014).  These criteria include diagnostic cut points for appendicular 
lean mass (ALM), gait speed (GS), and/or grip strength (GR), however cut-points do 
not agree between criteria.  This lack of consensus between classification criteria may 
result in large variability in sarcopenia classification depending on the set of criteria 
used.  That variation could result in inconsistent clinical classification of sarcopenia, 
the inability to compare research using different sets of classification criteria, and 
could lead to problems with identifying individuals for interventions.  
 Previously investigated treatment approaches for sarcopenia include diet and 
supplementation, hormonal therapies, and resistance training (RT) (Borst et al., 2014; 
Katsanos et al., 2008; Paddon-Jones & Leidy, 2014; Rossouw et al., 2002).  
Resistance training has been previously documented as an effective method of 
increasing lean mass, strength, and physical functioning in post-menopausal women 
and appears to be the most promising treatment method for sarcopenia (Fiatarone et 
al., 1994; Peterson, Rhea, Sen, & Gordon, 2010; Peterson, Sen, & Gordon, 2011; 
Rhodes et al., 2000).  Despite previous research, the effects of RT on sarcopenia 
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classification remain widely uninvestigated.  Periodized resistance training (PRT) 
programs use pre-planned variations of acute training program variables (exercise 
selection, order, intensity, volume, and rest) and has been shown to be superior to 
conventional RT (Fleck, 1999; Haff & Triplett, 2015; Rhea & Alderman, 2004).  A 
further subset of PRT is daily undulating periodization (DUP), which modifies 
program variables on a daily basis and has been shown to be superior to other forms of 
PRT (Prestes et al., 2009; Rhea, Ball, Phillips, & Burkett, 2002).  To date, DUP has 
not been investigated in older women who are sarcopenic or symptomatic and it is 
unclear if a DUP intervention would provide necessary increases in ALM, GS, and GR 
measures to alter sarcopenia classification by current criteria.  Therefore, the primary 
aim of this study was to investigate the effects of DUP on sarcopenia classification in 
older women with sarcopenia or symptoms of sarcopenia.  The secondary aim of this 
study was to evaluate the effects of DUP on individual measures of strength and 
global physical function. 
METHODS 
Design 
 This study utilized a randomized controlled trial design among a cohort of 25 
older, community dwelling women who met any component of sarcopenia 
classification criteria.  The study evaluated the effects of a 10-week DUP intervention 
as a method of changing sarcopenia classification within the cohort.  Secondary aims 
were to examine the effects of a 10-week DUP intervention on strength and physical 
functioning outcomes.  Data were collected at four time points; baseline, mid-point, 
post intervention, and 6-months post intervention. 
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Participants and setting 
 Participants were recruited from the local community surrounding the 
University of Rhode Island through a variety of methods including posters, newspaper 
advertisements, talks at senior centers and community centers, and word of mouth.  
All components of the study took place within the Kinesiology department at the 
University of Rhode Island, Kingston, Rhode Island, USA.  
Screening for eligibility and enrollment 
 Initial screening was conducted via telephone interview to include women who 
were postmenopausal, aged 65-84 years, not involved in a regular exercise program, 
and met at least one component of either EWGSOP (Cruz-Jentoft et al., 2010), IWG 
(Fielding et al., 2011), or FNIHSP (Studenski et al., 2014) sarcopenia classification 
criteria (i.e. low grip strength, low gait speed, etc.)  Reasons for study exclusion 
included failure to provide informed consent, inability to speak and read English, 
significant cognitive impairment, and the inability to safely engage in a mild to 
moderate intensity exercise.  Participants with recent major joint, vascular, abdominal 
or thoracic surgery were excluded, as well as participants who had physician 
diagnosed cardiovascular or pulmonary disease or an implanted pacemaker or 
defibrillator.  Uncontrolled diabetes, blood pressure, or anemia was reason for 
exclusion as were any medication changes within three weeks or changes to lipid 
lowering medication within six months.  
 Following the telephone interview, initially eligible participants visited the 
University of Rhode Island for an information session and a question and answer 
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session with primary investigators.  Participants then provided written informed 
consent and a teach-back process was also employed to ensure that participants 
understood the consent form.  Participants then completed a four-meter gait speed test, 
a handgrip strength test, a single chair stand test and a body composition test using an 
InBody 570 multi-frequency bioelectrical impedance analysis (BIA) device (Biospace 
Co, Ltd, Korea).  Participants’ ALM, GS, and GR data were then evaluated using 
EWGSOP, IWG, and FNISHP criteria to determine sarcopenia status.  The primary 
investigators then reviewed participants based on inclusion and exclusion criteria and 
sarcopenia status and determined study eligibility.  All participants selected to 
participate in the study obtained pre-participation medical clearance from their 
physician.  This study was approved by the Institutional Review Board of the 
University of Rhode Island.  
Interventions 
Periodized Daily Undulating Resistance Training Intervention   
 Participants in the periodized daily undulating resistance training intervention 
(DUP) group followed a program designed to target the entire body and trained three 
non-consecutive days per week for 45 minutes per session.  The training program 
incorporated exercises that progressed in complexity (e.g. leg press to deadlifts) and 
included the use of selectorized RT equipment and free weights.  This program 
modified program variables on daily basis and incorporated periods of low intensity 
work in an attempt to maintain participant interest in the program and prevent 
overtraining.  Higher intensity periods were also programmed to stimulate increases in 
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muscular strength and hypertrophy.  A depiction of the daily program variations is 
presented in Table 1.  Participants began every training session with a dynamic warm-
up and finished every session with a stretching cool down session.  National Strength 
and Conditioning Association Certified Strength and Conditioning Specialists 
instructed and supervised all training sessions.  
Active Control Group  
 The active control group (CON) underwent identical screening and testing 
processes as the DUP group; however, during the 10-week intervention this group met 
three times per week for 45 minutes per session and completed a program composed 
of exercises ranging from light to vigorous intensities (stretching, Tai Chi, aerobics, 
calisthenics).  Through the combination of warm up, moderate and vigorous intensity 
activity, and cool down the program approached the 150 minutes per week of 
moderate intensity physical activity for adults recommended by the ACSM (American 
College of Sports Medicine, 2009).  These activities, while beneficial to overall health, 
have not been shown to produce adaptations similar to those experienced in RT.  This 
style of control group was implemented to potentially reduce attrition and to provide a 
benefit for the “control” group. 
Measures 
 The primary outcome measure was sarcopenia classification.  Secondary 
outcome measures were body composition, chest, leg and grip strength, and global 
physical functioning.  Sarcopenia classification was conducted at baseline and post-
intervention.  Secondary measures were assessed at four time points: baseline, 5-
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weeks, post intervention, and 6-months post intervention.  All testing was conducted 
during the same time of day for all time points.  
Anthropometrics  
 Height was measured to the nearest 0.1 cm without shoes using a Seca wall 
mounted stadiometer and body weight was measured to the nearest 0.1 kg using a Seca 
balance beam scale (Seca, Chino, CA).  Both height and weight were measured in 
duplicate and the averages were used to calculate body mass index (BMI).  
Body Composition  
 Overall body composition was estimated using dual-energy x-ray 
absorptiometry (DXA) using fan-beam technology on a GE Lunar iDXA machine 
(GE, Waukesha, WI).  Participants reported to testing in a fasted state (~12 hours) and 
wore surgical scrubs during the test.  Standardized positioning procedures were 
followed and a licensed radiology technician performed all tests (Delmonico et al., 
2005).  Appendicular lean mass, total body fat mass, and percent fat were measured.  
Appendicular lean mass was considered the sum of non-bone lean mass in both arms 
and legs.  Total body lean mass was defined as lean soft tissue mass plus total body 
bone mineral content.  
Physical Functioning 
 Physical functioning was measured using several low burden tests.  The 
Established Populations for Epidemiologic Studies of the Elderly short physical 
performance battery (SPPB) includes a standing balance test, a four-meter gait usual 
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speed test, and timed five-chair stand test, and was conducted to assess each 
participant’s global physical functioning (Guralnik et al., 1994). The best gait speed 
score measured in the SPPB was used for sarcopenia classification. 
 To further evaluate physical functioning participants completed a 400-meter 
walk test, which is a valid and reproducible measure of physical functioning  
(Simonsick, Montgomery, Newman, Bauer, & Harris, 2001).  Participants also 
completed a timed up and go (TUG) test to measure physical functioning and mobility  
(Whitney, Lord, & Close, 2005).  The TUG test was conducted according to 
standardized protocol; participants were asked to rise from a 46-cm high chair, walk 
forward eight feet at their usual walking pace, turn 180° around a cone, walk back to 
the chair and sit down.  Measures were taken in duplicate, with the best score 
recorded. 
Grip Strength  
 Grip strength is a simple, safe, and effective method of predicting total body 
strength and future disability  (Laukkanen, Heikkinen, & Kauppinen, 1995; Rantanen 
et al., 1999).  Handgrip strength was measured in both hands with the participant in a 
seated position using a handgrip dynamometer and standardized protocols (Jamar 
Hydraulic Dynamometer, J.A. Preston, Corp., Jackson, MS) (Bellace, Healy, Besser, 
Byron, & Hohman, 2000).  Two trials per hand were completed and the highest score 
measured was used for sarcopenia classification. 
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Muscle Strength  
 All participants completed a familiarization with leg press and chest press 
machines one week prior to strength testing.  The familiarization included a dynamic 
warm-up, determination of proper seat and handle positions and instructions regarding 
proper exercise and breathing technique.  Participants then completed a set of 3-5 
repetitions on each machine using a load determined by the participant to be 
comfortable, then a second set of 3-5 repetitions at an increased intensity, followed by 
1-3 sets of progressively increasing intensity until the participant reached 80-90% of 
their maximal effort as rated on the Borg CR-10 scale (Borg, 1998). 
 Maximal leg press and chest press strength were assessed using previously 
published methods on Cybex seated leg press and chest press machines (Cybex 
International Inc., Medway, MA) (Delmonico et al., 2005; LeBrasseur, Bhasin, 
Miciek, & Storer, 2008).  Participants completed a dynamic warm-up prior to strength 
testing.  The leg press test required the participant to extend their knees from a starting 
position of ~90 degrees until the legs are fully extended, but not locked at the knees.  
The chest press test required the participant hold on to handles perpendicular to the 
chest, located at the height of the sternum and extended their elbows completely and 
return to the starting position in a controlled manner.  Participants followed a standard 
strength testing protocol and were given three minute rest periods between attempts 
(Fleck & Kraemer, 2014). 
Sarcopenia Classification 
 Following baseline testing, anthropometric, gait speed, grip strength, and ALM 
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data were used to determine sarcopenia classification by EWGSOP (Cruz-Jentoft et 
al., 2010), IWG (Fielding et al., 2011), and FNIHSP (Studenski et al., 2014) criteria 
published previously.  Following post-intervention testing, participants were re-
evaluated by the same classification criteria to determine any within group or between 
group changes in sarcopenia status as a result of the intervention.  
Nutritional Risk  
 The Dietary Screening Tool (DST) was used to assess the participants’ 
nutritional risk. The DST is a valid and reliable measure of dietary quality among 
older community-dwelling adults (Bailey et al., 2009).  Based on DST scores (0-100) 
participants were categorized based on nutritional risk levels: at risk (<60), possible 
risk (60-75), and not at risk (>75).   
Sample Size  
 Between-group changes for the primary outcome variable of sarcopenia 
classification were estimated to calculate sample size.  Data from Mason et al. (2013) 
were adjusted to reflect the duration of our study.  Those estimates indicated an 
expected between group difference in sarcopenia classification of 1.41±1% following 
a 10-week intervention.  Based on those estimations, a minimum of 10 participants per 
group was required to provide sufficient statistical power (0.80) to measure between 
group changes in sarcopenia classification. 
Randomization  
 Following the completion of baseline testing participants were randomized into 
a resistance training intervention group (RTI) or a control group (CON) using a 
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random number generator using Random Allocation Software (Isfahan University of 
Medical Sciences, Isfahan, Iran). 
Statistical Analysis  
 Continuous variables for primary and secondary outcomes were assessed for 
normality using Shapiro-Wilk tests.  Outliers were identified using box plots and 
Tukey’s method.  Any influential outliers were excluded from analyses.  Baseline 
characteristics were reported using descriptive statistics presented as means ± standard 
deviation.  Due to the paired nature of the data, changes in sarcopenia classification 
between groups were measured using McNemar’s tests.  Within and between group 
changes for all continuous variables were measured using mixed models analyses.  
Attrition rate was reported using descriptive statistics.  The alpha was set at p<0.05 for 
all analyses.  Analyses were performed using SAS version 9.3 (SAS Institute Inc, 
Cary, NC).   
RESULTS 
 A total of 160 participants were initially screened for study inclusion, 61 
participants signed informed consent and underwent secondary screening, and 25 
Caucasian women aged 72.3±4.6 years met all inclusion and exclusion criteria and 
were enrolled in the study (Figure 1).  All data points determined to be outliers did not 
influence significance, and were included in analyses.  The baseline physical 
characteristics of the participants are shown in Table 2.  There were no changes in 
nutritional risk measured by the DST.  As shown in Table 3, there were no significant 
within or between group changes in sarcopenia classification, by any set of criteria.  
Participants in DUP experienced reversals in sarcopenia classification by IWG (n=1) 
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and FNIHSP (n=2) criteria.  One participant in DUP also transitioned from sarcopenia 
to pre-sarcopenia by EWGSOP criteria.  The two changes in FNIHSP and one change 
EWGSOP classification were due to improvements in grip strength by the participants.  
The one change by IWG criteria was due to an improvement in gait speed.  
Participants in CON experienced reversals in sarcopenia classification by EWGSOP 
(n=1) and IWG (n=2) criteria.  The two participants who reversed their IWG 
classification did so by improvements in gait speed.  Those same two participants 
were also considered sarcopenic by EWGSOP criteria at baseline, and maintained that 
classification post intervention.  The one participant who reversed their EWGSOP 
sarcopenia classification did so by improvements in ALM/ht2.  No participants in 
CON met FNIHSP criteria at baseline or post-intervention.  
 As shown in Table 4, both DUP (p<0.001) and CON (p>0.001) showed 
significant improvements in gait speed, and chest and leg press strength.  Post 
intervention both DUP (p=0.001) and CON (p=0.046) experienced significant 
improvements in 400-meter walk time.  Post intervention DUP also showed a mean 
increase in grip strength of 2.45 kilograms, which was significantly greater than CON 
(p=0.024).  
DISCUSSION 
 These results present, for the first time, the effects of a 10-week periodized 
daily undulating resistance training intervention on sarcopenia classification in post-
menopausal women who presented with sarcopenia or symptoms of sarcopenia based 
on newly established classification criteria.  Our results indicate that when compared 
to an active control group, 10-weeks of DUP does not elicit significant changes in 
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sarcopenia classification within a sample of older, post-menopausal women.  
However, these results support the use DUP as a method of increasing muscular 
strength and physical functioning.  Moreover, when compared to an active control 
group, DUP will significantly increase grip strength in older sarcopenic women.  
Although our primary hypothesis was not supported, we present findings that indicate 
10 weeks of DUP or general exercise can significantly increase upper and lower body 
strength and physical functioning in older women with sarcopenia or symptoms of 
sarcopenia.  
 Other research investigating interventions for sarcopenia includes that of 
Mason et al. (2013), who investigated the effects of 12-months of aerobic exercise in 
76 post-menopausal women classified as sarcopenic using IWG lean mass cut points.  
That study found small (0.4%) but significant (p=0.004) increase in ALM/ht2.  
Although those results were significant, they are quite small, and indicate that regular 
aerobic training can attenuate further loss of lean mass, but not increase ALM over 
time.  Additionally, the women in that study did not undergo physical function testing, 
therefore the assessment of sarcopenia was not by full IWG criteria.  Nonetheless, our 
results agree with those of Mason et al. (2013) suggesting that regular physical activity 
could be beneficial for lean mass maintenance in those who are not sarcopenic.  
However, in older women with sarcopenia, treatments other than aerobic exercise are 
likely required to increase lean mass to the point of reversing sarcopenia classification.   
 Additionally, a recent study by Hassan et al. (2016) investigated the effects of 
six months of RT on sarcopenia classification in 42 adults aged 85.9±7.5 years, living 
in nursing homes.  Sarcopenia was classified using EWGSOP criteria and post-
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intervention there were no changes in sarcopenia classification in the intervention 
group.  That study also found significant increases in grip strength in their intervention 
group compared to the control group (p=0.002).  Our results are similar to those of 
Hassan et al. (2016), as we did not find any significant changes in sarcopenia 
classification post-intervention. However, that study only had six participants 
considered sarcopenic at baseline compared to our five participants in the DUP group 
who met EWGSOP criteria at baseline. While our findings agree that RT is effective at 
slowing the progression of sarcopenia, we also present the findings that 10-weeks of 
general exercise attenuates the loss of ALM.  However, our results and those of 
Hassan et al. (2016) demonstrate the need for future research to investigate 
intervention strategies in samples of older women with greater prevalence of 
sarcopenia at baseline.  
 Furthermore our findings indicate that increases in muscular strength, as 
measured by grip strength, were primarily responsible for changes in classification in 
the DUP group.  While improvements in physical function, measured by gait speed, 
were responsible for the majority of changes in classification by the CON group.  
These results suggest that DUP or general exercise can improve sarcopenia 
classification, albeit through different channels.  Our results also align with the recent 
findings of Santos et al. (2017) who found that a sample of 23 older women 
experienced significant increases in gait speed following eight weeks of RT.  The 
novel finding of that study was that the improvements in gait speed were associated 
with increases in lower body muscular strength and not muscle mass.  Our results 
corroborate those findings as both the DUP and CON group experienced significant 
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increases in both leg press strength and gait speed, while maintaining baseline levels 
of lean mass.  Our results present the new findings that DUP is a viable method of 
increasing gait speed and grip strength, independent of lean mass gains, and 
contributes to the body of literature regarding treatment methods for sarcopenia.  
 The unexpected strength increases of the CON group may be explained by 
Harber et al. (2009) who found that 12 weeks of aerobic training produced a 
significant (p<0.05) 55±7% increase in knee extensor power compared to baseline 
measures in a sample of seven older women aged 71±2 years.  A further study by 
Konopka et al. (2010) found that following 12 weeks of aerobic training a sample of 
nine older women maintained their overall body mass levels, and experienced small 
(0.5 kg) but significant increases in lean body mass.  Furthermore, those researchers 
also found that following training participants had significantly lower levels of 
myostatin mRNA expression, which they hypothesized, was partially responsible for 
the increases in lean mass.  While the mechanisms of myostatin expression in relation 
to aging are not completely understood, research has shown that inhibition of 
myostatin can lead to increases in lean mass in post-menopausal women (Attie et al., 
2013; White & LeBrasseur, 2014).  While Konopka et al. (2010) had a relatively small 
sample size, the finding of decreased myostatin expression following aerobic exercise 
may partially explain the maintenance of lean mass in our CON group and present a 
possible avenue for future research investigating myostatin suppression and its effects 
on sarcopenia.  
 Furthermore, our results suggest that the FNIHSP criteria is more conservative 
with sarcopenia classification than the EWGSOP and IWG criteria.  The EWGSOP 
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and IWG criteria classified a combined 14 participants as sarcopenic at baseline, while 
the FNIHSP criteria only found two DUP participants to be weak with low lean mass 
at baseline.  Interestingly, both participants that met FNIHSP criteria had BMIs >30, 
which is consistent with the results of Dam et al. (2014) who found individuals who 
met FNIHSP criteria to be heavier with larger BMIs compared to those who met 
EWGSOP or IWG criteria.  Consequently, the FNIHSP criteria may be more 
appropriate for obese populations, while the EWGSOP and IWG criteria identify more 
individuals as sarcopenic and may be better suited for those with BMIs <30.  
 Considering the maintenance of ALM experienced by both groups, future 
research should investigate the potential effects of interdisciplinary interventions on 
sarcopenia classification, particularly the combined effects of DUP and a diet or 
supplementation intervention.  A recent study by Bauer et al. (2015) found that after 
13 weeks of whey protein and vitamin D supplementation, older, sarcopenic men and 
women experienced significant (p=0.045) increases in ALM when compared to a 
control group.  Moreover, Cangussu et al. (2015) found that older, post-menopausal 
women who supplemented with vitamin D experienced significant (p<0.0001) 
improvements in chair stand tests compared to a control group.  Based on those 
results, supplementation could provide older sarcopenic women with significant 
increases in ALM and physical function.  Supplement induced increases in ALM 
combined with DUP induced increases in strength and physical function could present 
a strong method of altering sarcopenia classification in older women.  
 This pilot study has demonstrated the feasibility of delivering a 10-week DUP 
intervention to a group of older, post-menopausal women who had sarcopenia or 
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symptoms of sarcopenia at baseline.  Additionally this study had high external 
validity, as the RT equipment used is common among most fitness centers, and 
training three days per week is a feasible task for older adults.  Attendance for the 
DUP group averaged 85.2±7.8%, while the CON group averaged 82.6±7.2%.  
Additionally, only three participants were lost to follow up (12% attrition).  This 
indicates that it is feasible and safe to deliver a three-day per week, DUP intervention 
to older sarcopenic women without any injury or undue attrition. 
 This study had several limitations including sample size and intervention 
duration.  Having a sample size of 25 participants limited our ability to measure 
between group differences and gauge the success of the intervention.  The cohort was 
also 100% Caucasian, which enhances the applicability of results to that population, 
but limits applicability of results to those of differing race.  Furthermore, only seven 
participants in each group met sarcopenia classification criteria at baseline.  The small 
exposure to cases of sarcopenia may have limited the ability to measure changes in 
sarcopenia classification, which was also a limitation of Hassan et al. (2016). 
Additionally, the use of an active control group may have influenced the results of 
CON.  However in an invited commentary Booth & Lees contend that interventions 
investigating exercise should include active control participants rather than traditional 
sedentary controls  (Booth & Lees, 2006).  Moreover, the intervention duration of 10-
weeks may have impacted our ability to observe lean mass increases that would alter 
sarcopenia classification, as research indicates that muscle hypertrophy typically 
begins 6-8 weeks after onset of training, which limited the amount of time for 
measureable hypertrophy to occur (Deschenes & Kraemer, 2002).  However, previous 
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studies have experienced significant increases in lean mass in 8 and 10 weeks, albeit in 
larger samples, indicating the potential for measurable hypertrophy in shorter duration 
interventions  (Delmonico et al., 2005; Santos et al., 2017).  Future research should 
seek to investigate longer duration DUP interventions in larger samples of older 
women with higher prevalence’s of sarcopenia at baseline.  Nonetheless, our results 
indicate that 10-weeks of DUP improved strength and physical function, and 
attenuated the age related loss of muscle mass in this sample.  
  
CONCLUSION 
 In conclusion, this study presents novel new information regarding the use and 
feasibility of DUP as a potential treatment for sarcopenia in older, post-menopausal 
women.  Our results indicate that through either general exercise or DUP, older 
women with sarcopenia or symptoms of sarcopenia can significantly increase their 
strength and physical functioning.  Although, to garner maximum strength benefits 
older women should engage in DUP rather than general exercise.  These results 
provide a new substrate from which future research can build upon to further 
investigate which forms of treatment provide the greatest change in sarcopenia 
classification in older women.  
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TABLES 
 
Table 1. Daily undulations of program variables   
 
 
L= Light day (12 repetitions, 60 seconds rest, 70% RM); 
M= Medium day (8-10 repetitions, 90-120 seconds rest, 75-80% RM);  
H= Heavy day (3-6 repetitions, 120-180 seconds rest, ≥85% RM). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Day 1 Day 2 Day 3 
Week 1 L M H 
Week 2 L H M 
Week 3 L M H 
Week 4 M L M 
Week 5 H M L 
Week 6 M H H 
Week 7 L H H 
Week 8 M L H 
Week 9 M H M 
Week 10 H H M 
 28  
Table 2. Baseline characteristics of participants  
 
  Total (n=25) DUP (n=13) CON (n=12) p-value 
Age (years) 72.3±4.6 71.8±4.8 72.9±4.6 0.547 
Attendance (%) 84.0±7.5 85.2±7.8 82.6±7.2 0.270 
Body mass (kg) 65.4±13.5 68.7±15.5 61.8±10.3 0.205 
Height (cm) 159.8±5.2 160.0±5.7 159.6±4.8 0.851 
BMI 25.7±5.9 27.1±7.3 24.2±3.5 0.446 
Body Fat (%) 42.5±6.3 43.9±7.8 41.0±3.9 0.256 
ALM/ht2 (kg/m2) 5.92±1.1 6.13±1.3 5.69±0.8 0.330 
ALM/BMI 0.60±0.07 0.59±0.09 0.60±0.04 0.751 
Systolic BP (mmHg) 122.8±14.7 129.1±14.2 116.0±12.4 0.022* 
Diastolic BP (mmHg)  74.5±8.5 77.9±7.5 70.8±8.2 0.034* 
Chest press (kg) 17.0±6.6 17.8±8.4 16.1±4.3 0.624 
Leg press (kg) 46.3±16.1 50.6±18.5 41.7±12.2 0.220 
Grip strength (kg) 16.6±3.7 17.5±4.5 15.8±2.6 0.492 
SPPB 10.2±1.6 10.7±1.6 9.8±1.5 0.359 
Gait speed (m/s) 1.05±0.14 1.07±0.16 1.02±0.12 0.398 
TUG (s) 7.5±1.1 7.1±0.9 7.8±1.1 0.101 
400 meter walk (s) 313.2±42.8 311.9±40.0 314.7±47.4 0.874 
Abbreviations: BMI, Body Mass index; ALM, appendicular lean mass measured via dual-energy  
X-ray absorptiometry; SPPB, Short Physical Performance Battery; TUG, Timed up                             
and go. 
Data presented as means ± standard deviation.   
P-values obtained using t-tests.  
*Indicates p-value <0.05 
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Table 3. Baseline and post intervention changes in sarcopenia classification using different national and international                    
sarcopenia classification criteria.  
  
  
DUP CON DUP vs. CON p-value 
Baseline Post p-value Baseline Post p-value Baseline Post 
EWGSOP 
  
  
  
  
 
  
  Normal 7 (58.3) 8 (72.7) 0.186 5 (41.7) 5 (50.0) 0.445 0.416 0.289 
  Sarcopenia 5 (41.7) 3 (27.3) 0.186 7 (58.3) 5 (50.0) 0.445 0.416 0.289 
  Severe Sarcopenia  0 (0.0) 0 (0.0) - 0 (0.0) 0 (0.0) - - - 
IWG 
  
  
  
  
 
  
  Normal 9 (81.8) 9 (100) - 10 (83.3) 10 (100) - 1.000 - 
  Sarcopenia 2 (18.2) 0 (0.0) - 2 (16.7) 0 (0.0) - 1.000 - 
FNIHSP 
  
  
  
  
 
  
   Normal 10 (83.3) 11 (100) - 12 (100) 10 (100) - - - 
   Weak + low lean mass 2 (16.7) 0 (0.0) - 0 (0.0) 0 (0.0) - - - 
   Weak + slow + low lean mass 0 (0.0) 0 (0.0) - 0 (0.0) 0 (0.0) - - - 
Abbreviations: DUP, Daily undulation periodization resistance training group; CON, active control group; EWGSOP, European Working                              
Group on Sarcopenia in Older People; IWG, International Working Group on Sarcopenia; FNIHSP, Foundation for the National Institutes of  
Health Sarcopenia Project.  
Data are expressed as number of participants (% of sample) 
P-values were obtained using McNemar’s Test or binomial exact test if discordant cell frequency was less than 4  
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Table 4. Mean changes in physical function, body composition, and strength measures   
compared to baseline values. 
 CON DUP DUP vs. CON 
 Mean ± SD   p-value  Mean ± SD p-value p-value GS (s)              Baseline REF   REF   0.383 
    Mid point 1.45±2.79 0.002* 1.08±3.56 <0.001* 0.265 
    Post Testing -0.65±0.59 <0.001* -0.55±0.46 0.001* 0.641 
    6 month -0.40±0.37 0.036* -0.08±0.38 0.793 0.472 
DXA ALM (kg)              Baseline REF   REF  0.309     Post Testing 0.15±0.53 0.298 0.17±0.37 0.216 0.304 
ALM/ht2 
(kg/m2) 
             Baseline REF   REF  0.326     Post Testing -0.05±0.16  0.256 -0.04±0.23 0.392 0.35 
ALM/BMI              Baseline REF   REF  0.756     Post Testing  0.61±0.05 
 
0.213 0.59±0.09 0.92 0.587 
GR (kg)              Baseline REF   REF  0.195     Midpoint 1.45±2.79 0.144 1.08±3.56 0.203 0.303 
    Post Testing 0.50±1.90 0.644 1.67±4.48 0.06 0.036* 
    6 month -0.10±3.11 0.861 0.25±3.45 0.785 0.127 
CP (kg)              Baseline REF   REF  0.567     Midpoint 2.18±1.41 <0.001* 3.56±1.70 <0.001* 0.295 
    Post Testing 2.68±1.76 <0.001* 5.13±2.50 <0.001* 0.149 
    6 month  1.94±1.99 <0.001* 3.24±1.93 <0.001* 0.299 
LP (kg)              Baseline REF   REF  0.265     Midpoint 10.95±4.57 <0.001* 13.34±11.97 <0.001* 0.171 
    Post Testing 17.9±8.02 <0.001* 20.8±14.2 <0.001* 0.153 
    6 month 12.50±6.95 <0.001* 15.08±10.90 <0.001* 0.234 
SPPB              Baseline REF   REF  0.062     Midpoint 1.10±1.20 0.041* 0.38±1.56 0.372 0.511 
    Post Testing 1.40±1.78 0.008* 1.00±1.91 0.039* 0.273 
    6 month 1.70±1.95 0.001* 0.58±1.88 0.25 0.802 
400m walk (s)              Baseline REF   REF  0.866     Midpoint -20.23±18.00 0.012* -14.29±29.95 0.035* 0.894 
    Post Testing -20.89±23.99 0.01* -18.95±33.42 0.007* 0.912 
    6 month  -23.68±23.77 0.003* -14.61±33.61 0.035* 0.756 
TUG (s)             Baseline REF   REF  0.101    Midpoint -0.94±0.59 <0.001* -0.38±0.88 0.087 0.718 
   Post Testing -0.74±0.56 0.005* -0.48±1.04 0.056 0.342 
   6 month -0.13±0.69 0.646 0.91±0.70 <0.001* 0.404 
Abbreviations: DUP, Daily undulation periodization resistance training group; CON, active control                  
group; GS, gait speed; DXA ALM, appendicular lean mass measured via dual-energy X-ray                   
absorptiometry; ALM/ht2, appendicular lean mass divided by height in meters squared; ALM/BMI,        
appendicular lean mass divided by body mass index; GR, grip strength; CP, chest press strength;                           
LP, leg press strength; SPPB, Short Physical Performance Battery; TUG, Timed up and go; 6 month,                       
six months post intervention, REF, baseline values set as referent values.  
Data are presented as means ± standard deviation, with values for each time point representing change 
from baseline value 
Analyses were conducted using mixed models with baseline values set as referent value. 
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FIGURES 
 
Figure 1. Study Flow Chart. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Assessed for eligibility (n=160) 
Excluded  (n=135) 
¨   Not meeting inclusion criteria 
(n=106) 
¨   Declined to participate (n=29) 
  
Analyzed  (n=12) 
-Excluded from all analyses (n=1) 
-One participant lost to follow up was included 
in baseline analyses 
-One participant who completed intervention 
was excluded from post-intervention 
sarcopenia analysis due to missing gait speed 
data 
Lost to follow-up (n=1) 
Injury unrelated to intervention (n=1) 
Allocated to DUP (n=13) 
 
Discontinued intervention (n=2) 
Unable to make time commitment (n=1) 
Unhappy with randomization results (n=1) 
Allocated to CON (n=12) 
 
 
  Analyzed  (n=10) 
-Two participants lost to follow up were 
included in baseline analyses 
 
Analysis 
Follow-Up 
Randomized (n=25) 
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APPENDICES 
Appendix A: Review of the Literature 
Abstract 
 The age related loss of muscle mass, known as sarcopenia can negatively affect 
physical functioning and muscular strength.  Older women may be at a greater risk for 
sarcopenia and functional impairments due to gender specific differences in the aging 
process.  Current classification criteria for sarcopenia developed by the European 
Working Group on Sarcopenia in Older People (EWGSOP), the International Working 
Group (IWG), and the Foundation for the National Institutes of Health Sarcopenia 
Project (FNIHSP) lack agreement, however most criteria incorporate measures of 
appendicular lean mass (ALM), muscular strength, and physical functioning.  
Resistance training (RT) is known to produce increases in muscle mass, strength, and 
improve physical function in older individuals.  Periodized resistance training (PRT) is 
a form of RT program design, which modifies program variables in an attempt to 
maximize performance, and has been shown to be superior to conventional RT 
program design at eliciting gains in strength and physical functioning.  To date no 
study has evaluated the effects of PRT on sarcopenia classification in older women.  
 
Introduction 
 The term sarcopenia, originally coined in 1989 by Dr. Irwin Rosenberg, 
originates from the Greek language and translates to “poverty of the flesh” 
(Rosenberg, 1989).  Sarcopenia has been reported as a global public health problem, 
and results in a gradual, age-accelerated loss of skeletal muscle mass, which can 
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negatively affect physical functioning and muscular strength (Chen et al., 2014; 
Cherin, Voronska, Fraoucene, & de Jaeger, 2014; Cruz-Jentoft et al., 2014; Diz et al., 
2016; W. Kemmler et al., 2015; Tichet et al., 2008).  While sarcopenia is related to 
aging, several mechanisms are associated with this multifactorial process.  Factors 
including decreased levels of physical activity, hormonal changes, altered nervous 
system activity, muscle fiber atrophy, loss of type 2 muscle fibers, and fatty 
infiltration of skeletal muscle all contribute to the accelerated loss of skeletal muscle 
(Alchin, 2014; Karakelides & Nair, 2005; Kostek & Delmonico, 2011).  Following 
age 50 muscle mass decreases at a rate of 1-2% per year (Batsis, Mackenzie, Barre, 
Lopez-Jimenez, & Bartels, 2014).  Evidence suggests this progressive muscular 
atrophy contributes to rapid declines in muscle strength, power, and physical function; 
placing older individuals at risk for injury and/or disability (Batsis et al., 2014; 
Cawthon et al., 2011; Choi, 2013; Visser et al., 2005; Yang, Ding, Luo, Hao, & Dong, 
2014).  
 Furthermore, Jannssen et al. (2004) estimated that the healthcare costs directly 
associated with sarcopenia in 2000 were $18.5 billion, with more than $7 billion 
attributed to older women.  Those estimates, coupled with the projected increase in the 
older population indicate that appropriate diagnostic and treatment strategies need to 
be developed in order to combat sarcopenia in older adults (Administration on Aging, 
2014).  Moreover, women typically live longer than men and therefore may have an 
increased risk of functional impairment as they age (Barford, Dorling, Davey Smith, & 
Shaw, 2006; Borst, 2004). 
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 Currently there is no universally accepted definition or classification criteria 
for identifying sarcopenia in older individuals.  However, several working groups have 
developed diagnostic criteria that include cut-points for low levels of ALM, low 
strength, and physical functioning markers.  Although the current cut points and 
quantification variables do not agree, the European Working Group on Sarcopenia in 
Older People (EWGSOP), the International Working Group (IWG), and the 
Foundation for the National Institutes of Health Sarcopenia Project (FNIHSP) all 
concur that measures of ALM and/or grip strength or gait speed are necessary to 
classify an individual as sarcopenic (Cruz-Jentoft et al., 2010; Fielding et al., 2011; 
Studenski et al., 2014). 
 Treatment of sarcopenia centralizes around mechanisms that aim to maintain 
or increase levels of lean mass and physical functioning.  Current approaches include 
hormone treatments, supplementation treatments, and physical activity or RT 
interventions (Anton et al., 2016; Evans, Boccardi, & Paolisso, 2013; Kim et al., 2012; 
Solerte et al., 2008).  All of these treatment modalities have strengths and weaknesses, 
however RT has been shown to be the most effective method of increasing muscle 
mass and physical function, with little to no accompanying side effects  (Foster-Burns, 
1999; Marcell, Hawkins, & Wiswell, 2014; Paddon-Jones, Short, Campbell, Volpi, & 
Wolfe, 2008; Sorensen, Rosenfalck, Hojgaard, & Ottesen, 2001; Stewart, Saunders, & 
Greig, 2014).  
 Periodized resistance training (PRT) is a form of RT program design that has 
elicited greater performance gains when compared to traditional RT programming 
(Kraemer et al., 2003; Monteiro et al., 2009; O'bryant, Byrd, & Stone, 1988).  While 
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RT in older adults has been researched previously, no study has investigated if an 
intervention using a specific form of PRT: daily undulating periodized resistance 
training (DUP), would elicit changes in sarcopenia classification in older women 
considered sarcopenic by current criteria.  
 
Sarcopenia in Older Women 
 Recent population estimates indicate a greater percentage of the older 
population is female, and they have a longer life expectancy and are at a greater risk of 
physical disability compared to men (Administration on Aging, 2014; Borst, 2004; 
Carrière et al., 2005).  Additionally, compared to men, women typically have lower 
amounts of lean mass and lower levels of physical activity in old age, resulting in an 
increased risk of developing sarcopenia (Batsis et al., 2014; Chad et al., 2005).  As 
shown in a study by Chad et al. (2005), 67% of women over the age of 50 are not 
active enough to achieve a reduction in chronic disease risk.  Moreover, hormonal 
changes due to menopause result in decreases in lean mass accompanied by increases 
in fat mass, independent of age (Douchi et al., 1998; Orsatti et al., 2016).  While men 
also experience decreases in testosterone that contribute to losses of muscle mass, 
women begin to experience changes in estrogen up to 10 years prior to the onset of 
menopause, contributing to pre-menopausal declines in muscle mass, bone mass, and 
strength (Brown, 2008; Burger, Hale, Robertson, & Dennerstein, 2007; Delmonico & 
Beck, 2015).  Due to the increased risk of sarcopenia in older women detection and 
intervention strategies are critical to prevent and treat sarcopenia in this population.   
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 In a study assessing 18,913 older U.S. and English men and women, U.S. 
women experienced the steepest decline in measures of activities of daily living and 
physical function when compared to other study participants at eight years of follow 
up (Bendayan et al., 2016).  Those researchers also determined that activities 
incorporating climbing stairs, kneeling down, or crouching were the first to decline 
among their cohort. That study indicates that as women in the U.S. age, they will 
likely experience declines in the ability to perform activities of daily living, therefore 
treatment strategies are necessary to regain physical function in older women.  
 Sarcopenia has also been associated with an increased risk of all-cause 
mortality.  A recent meta-analysis by Chang & Lin (2016) analyzed 10 longitudinal 
studies with 3,797 men and women with an average follow up of 4.17 years.  
Sarcopenia was classified using three different sets of criteria including EWGSOP 
criteria.  With non-sarcopenic participants considered the referent group there was 
there was a significantly increased risk of all-cause mortality in those considered to 
have sarcopenia (HR:1.87, 95% CI: 1.61-2.18).  The finding that sarcopenia increased 
the risk of all-cause mortality underscores the impact of sarcopenia in older adults.  
Therefore, prevention and treatment of this condition is necessary in this population.  
The body of evidence within the literature indicates that sarcopenia is a 
significant public health issue, especially in older women.  As the population over 65 
grows, it can be inferred that the prevalence of sarcopenia, the risk of all cause 
mortality, and healthcare expenses within this population will also increase.  Therefore 
it is imperative that intervention strategies be developed to help attenuate the loss of 
physical functioning, lean mass and muscular strength in older women.  
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Dynapenia vs Sarcopenia    
 Dynapenia, in contrast to sarcopenia, is defined as the age related loss of 
muscular strength that is not associated with any neurological or muscular disease 
(Clark & Manini, 2012; Mitchell et al., 2015).  Dynapenia is distinct from sarcopenia, 
however these two conditions are similar as research indicates that muscular strength 
and muscle mass are closely related (Clark & Manini, 2008; Reed, Pearlmutter, 
Yochum, Meredith, & Mooradian, 1991).  Similar to sarcopenia, dynapenia is a 
multifactorial process influenced by changes to the nervous system and the muscular 
system.  Clark & Manini (2008) argue that decreased strength (dynapenia) may have a 
greater influence on physical functioning in older individuals than decreased muscle 
mass (sarcopenia).  Those researchers contend that future research should focus on 
methods of preventing the loss of strength rather than muscle mass.  However, the 
term sarcopenia is more widely recognized within the literature than dynapenia, and 
current sarcopenia classification criteria include measures of muscular strength.  
Furthermore, current criteria have been developed to be comprehensive clinical 
assessments, as individual diagnoses of low mass or low strength may be of limited 
clinical value (Cruz-Jentoft et al., 2010; Delmonico & Beck, 2015).   
 Clark & Manini (2008) clearly demonstrate that muscular strength is vital to 
maintaining physical function and completing activities of daily living.  While there 
are various methods of assessing muscular strength in older individuals, few are as 
easy and portable to assess as grip strength.  Isometric handgrip strength is related to 
lower body power and has also been shown to be a valid clinical marker of mobility 
(Lauretani et al., 2003).  Additionally, research has shown a linear relationship 
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between handgrip strength and future disability for activities of daily living (Al Snih, 
Markides, Ottenbacher, & Raji, 2004).  Due to the ease, affordability, and validity of 
this measure, handgrip strength is present in some sarcopenia classification criteria.  
However, this measure is not without limitations.  Despite being a valid predictor of 
total body strength and future disability, grip strength may not be a valid measure for 
older individuals with hand ailments such as arthritis (Erol, Ceceli, Uysal Ramadan, & 
Borman, 2016; Rantanen et al., 1999).  
 
Importance of Gait Speed  
 Ambulation is a vital component of activities of daily living and its importance 
in overall physical functioning cannot be understated.  Indeed some researchers 
suggest that gait speed should be considered the “sixth vital sign” and assessed 
clinically along with breathing, temperature, heart rate, pain, and color (Fritz & 
Lusardi, 2009).  A study by Studenski et al. (2011) examining gait speed and survival 
in 34,485 older adults found that lower levels of gait speed were associated with 
increased risk of mortality.  Additionally, those researchers determined an overall 
hazard ratio of 0.88 (95% CI: 0.87-0.90) for each 0.1-meter per second (m/s) increase 
in gait speed.  The results of that study suggest that older adults with poor gait speed 
and therefore reduced physical function are at a greater risk of all-cause mortality.  
Gait speed is also easy and inexpensive to measure, with the only requirements being a 
stopwatch and a pre-measured distance.  Test distances for gait speed have varied 
from 2 to 40 meters in length, however for patient and clinician practicality and 
feasibility, it is recommended that tests not exceed 10 meters in distance (Middleton, 
 39  
Fritz, & Lusardi, 2015).  While protocols for specific tests may vary, gait speed tests 
are a validated method of assessing overall physical function in older adults.  
Considering the immense importance of gait speed in relation to physical function and 
mortality including this measure in routine medical assessments would allow 
clinicians to monitor gait speed trajectory and determine if an individual’s gait speed 
is improving or deteriorating.  
 Consequently, while the term sarcopenia by definition refers to the age related 
loss of muscle mass; some current sarcopenia classification criteria include measures 
of muscle mass, strength, and physical function.  These criteria allow for a more 
comprehensive evaluation of individuals’ overall health and physical function and 
may be beneficial for the detection of functional impairment in older individuals, 
regardless of the underlying mechanism or terminology.  
 
Sarcopenia Classification    
 Researchers have faced difficulties designing and justifying interventions 
strategies for older adults with sarcopenia in part due to the lack of consensus 
definition/diagnostic criteria for sarcopenia and inability to compare results of 
different studies (Cruz-Jentoft et al., 2014).  In addition, sarcopenia lacks significant 
clinical endpoints (e.g. fracture risk for osteoporosis), making it difficult to pinpoint 
the onset of the condition (Studenski et al., 2014).  One of the earliest and most 
common methods of sarcopenia diagnosis is the skeletal muscle index (SMI) method 
(Baumgartner, Waters, Gallagher, Morley, & Garry, 1999).  The SMI method is 
calculated by dividing ALM in kilograms by height in meters squared (kg/m2), where 
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ALM is measured via dual energy x-ray absorptiometry (DXA), and considered the 
sum of non-bone lean mass in both arms and legs.  Baumgartner et al. (1998) first used 
the SMI method in the New Mexico Aging Process study.  That study classified 
sarcopenia in an older population using sex specific SMI cut points that were two 
standard deviations below the mean SMI of a healthy young adult population from the 
Rosetta Study (Baumgartner et al., 1998; Gallagher et al., 1997).  The inclusion of 
height in the SMI is beneficial as taller individuals often have more ALM.  Indeed, 
further data from the New Mexico Aging Process Study showed that 38% of the 
variance in muscle mass measurements in older women was attributable to height 
differences, which demonstrates the need to account for skeletal size when assessing 
lean mass (Baumgartner et al., 1999).   
 Although the SMI method accounts for height and can be used with sex 
specific cut points, it is limited in that it doesn’t account for fat mass and may fail to 
classify obese individuals as sarcopenic.  This became evident when two separate 
studies analyzed data from the Health, Aging, and Body Composition (Health ABC) 
study.  The first study by Newman et al. (2003) included data from 2,984 men and 
women aged 70-79 years.  That study used two different methods of classifying 
sarcopenia in their cohort: the SMI method and a proposed new method of classifying 
sarcopenia using linear regression residuals.  However in their use of the SMI method 
they did not compare participant data to that of a healthy reference population as 
Baumgartner et al. (1998) did, rather a participant was considered sarcopenic is their 
SMI value fell below the 20th percentile of the sex-specific distribution of values 
within the Health ABC cohort.  The residuals method also uses ALM in its sarcopenia 
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classification however this method also accounts for fat mass.  In order for those 
researchers to model the relationship between fat mass, height, and ALM, a linear 
regression was performed.  The residuals of this regression were then used to 
determine sarcopenia classification.  Any participant who fell below the 20th percentile 
of the residuals of the Health ABC cohort was considered sarcopenic.  This allowed 
for direct comparison with the SMI method using the 20th percentile cut point. 
 The results of Newman et al.’s (2003) investigation indicated that when 
applying the SMI method to overweight and obese women 0.8% and 0%, respectively, 
of the population was considered sarcopenic.  Conversely, the residuals method 
reported 21.7% and 21% sarcopenia prevalence’s in overweight and obese women 
respectively.  Furthermore, when assessed using the residuals method, women had 
higher adjusted odds of lower extremity functional limitation (OR: 1.9, 95% CI: 1.4-
2.5), than when they were assessed with the SMI method (OR: 0.9, 95% CI: 0.7-1.2). 
 The second study using Health ABC data by Delmonico et al. (2007) included 
a sample of 2,976 older men and women aged 70-79 at baseline.  Participant data were 
assessed using the SMI method and the 20th percentile of the Health ABC population 
cut point and the 20th percentile of linear regression residuals cut point.  Those 
researchers found that after five years of follow up the residuals method predicted 
increased risk of lower extremity limitation (HR: 1.34, 95% CI: 1.11-1.61) while the 
SMI method initially predicted improvement in lower extremity (HR: 0.58, 95% CI: 
0.48-0.72).  However after adjustment for confounders including age, race, physical 
activity, and total body fat mass, the SMI results appeared to insignificantly predict 
future functional limitation (HR: 1.04, 95% CI: 0.82-1.31).  
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 Those results demonstrate the limitations of using the SMI method to classify 
sarcopenia, especially in populations with a high prevalence of overweight and/or 
obese individuals.  This also demonstrates the importance of including measures such 
as fat mass or percent body fat into classification criteria, and that the residuals 
method may offer better prediction of future incidence of functional limitations 
(Delmonico et al., 2007; Newman et al., 2003).  Despite those findings some current 
sarcopenia classification criteria use the SMI method of quantifying lean mass and 
include measures of physical functioning and strength rather than fat mass, while other 
criteria have the ability to account for fat mass.  To that end, based on the findings of 
Newman et al. and Delmonico et al., in order for sarcopenia classification criteria to be 
most applicable different populations a measure of fat mass should be included in 
ALM assessment. 
 Currently the most prominent sarcopenia classification criteria have been 
established by the European Working Group on Sarcopenia in Older People 
(EWGSOP), the International Working Group (IWG), and the Foundation for the 
National Institutes of Health Sarcopenia Project (FNIHSP) and are presented in 
Literature Review Table 1 (Cruz-Jentoft et al., 2010; Fielding et al., 2011; Studenski et 
al., 2014).  All of these working groups included diagnostic cut points for lean mass, 
muscular strength (grip strength), and/or physical function (gait speed) for both men 
and women in their criteria.  The cut points for women will be discussed in this 
review.  The EWGSOP criteria includes measures of lean mass, physical function, and 
strength and incorporate established stages of sarcopenia: pre-sarcopenia, sarcopenia, 
and severe sarcopenia.  In their consensus statement the EWGSOP lists various SMI 
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cut points depending on the method used to measure ALM (DXA, bioelectrical 
impedance, MRI, etc.).   
 
 
 
 
 
 
 
 
 
 
They also include 20th percentile cut points for the residuals method.  To be 
considered pre-sarcopenic one must score below one of the established lean mass cut 
points presented in their criteria.  In order to be considered sarcopenic one must score 
below the cut point for ALM and gait speed (<0.8 m/s), or grip strength (<20 kg).  A 
severe sarcopenia classification would require one to score below the cut points for 
gait speed, grip strength, and ALM.  Although they state that they have reached a 
consensus agreement on proper sarcopenia classification criteria, the EWGSOP 
includes various different methodologies of evaluating and quantifying lean mass, 
strength, and physical functioning.  This does not appear to be true consensus criteria, 
rather a list of multiple suggested methodologies and cut points that can used to screen 
for sarcopenia.  Nonetheless, the EWGSOP criteria are widely featured among the 
Literature Review Table 1: Current sarcopenia classification criteria for older women 
The European Working Group on Sarcopenia in 
Older People Sarcopenia (EWGSOP) and 
International Working Group on Sarcopenia 
(IWG) screening guidelines for sarcopenia and 
severe sarcopenia in older women 
The Foundation for the National Institutes 
of Health Sarcopenia Project (FNIHSP) 
recommended modalities and cut-points 
for identifying functional limitation, 
muscle weakness and low lean mass in 
older women.  
 Sarcopenia EWGSOP IWG Weak with Low Lean Mass Cut-Point 
 Gait Speed < 0.8 m/s < 1.0 m/s Gait Speed - 
  OR  Weakness: Grip strength < 16 kg 
 Grip Strength < 20 kg N/A Lean Mass: ALM/BMI < 0.512 
  AND  Weak and Slow with Low Lean Mass 
 
 Lean Mass: ALM/ht2 < 5.67 kg/m2 < 5.67 kg/m2 Gait Speed < 0.8 m/s 
Severe Sarcopenia   Weakness: Grip strength <16 kg 
 Gait Speed < 0.8 m/s N/A Lean Mass: ALM/BMI < 0.512 
  AND  Abbreviations: ALM, appendicular lean mass; BMI, body mass index. 
Lean mass cut points for all criteria are for use 
with ALM measured via dual energy x-ray 
absorptiometry 
 
 Grip Strength < 20 kg N/A 
  AND  
 Lean Mass: ALM/ht2  < 5.67 kg/m2 N/A 
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current literature (Bahat et al., 2016; Beaudart et al., 2014; Masanés et al., 2016; Patel 
et al., 2015; Wen, An, Chen, Lv, & Fu, 2015).   
 In contrast, the IWG criteria use a “yes” or “no” sarcopenia classification.  To 
receive a “yes” classification one must score below a SMI cut point of 5.67 kg/m2 and 
below a gait speed cut point of 1.0 m/s.  The IWG also suggests the use of a single 
chair stand as an indicator of overall strength.  While the chair stand is not included in 
the “yes” or “no” classification criteria it may be more indicative of overall strength 
and the ability to complete activities of daily living than grip strength alone 
(Delmonico & Beck, 2015; Fielding et al., 2011).  There appears to be less variation in 
how to use the IWG criteria, as for women there is only one cut point for ALM and 
one cut point for gait speed.  Interestingly, the SMI cut point of 5.67 kg/m2 is the same 
cut point developed by Delmonico (2007) and Newman (2003) that represents the SMI 
of the lowest 20% of the Health ABC cohort.  
 The FNISHP criteria use a somewhat different method of stratifying 
sarcopenia classification.  Those criteria use “weak with low lean mass” and “weak 
and slow with low lean mass” to classify sarcopenia.  Those criteria also utilize a 
different variable to quantify lean mass: ALM divided by body mass index (BMI).  
This measure was developed by Cawthon et al. (2014) who through classification and 
regression tree analysis of ALM data and grip strength data from 14 studies, 
developed lean mass cut points that were highly related to accompanying weakness in 
women (OR: 2.2, 95% CI: 1.8-2.8).  This departure from the SMI method of 
quantifying lean mass underscores the need to at least account for body mass, if not fat 
mass in cut point development.  It remains to be seen if this method will aid in the 
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detection of sarcopenic obesity by including a measure of overall body mass.  A 
“weak with low lean mass” diagnosis requires a woman to score below cut points for 
both grip strength (<16 kg) and ALM/BMI (<0.512), while a “weak and slow with low 
lean mass” diagnosis would also require meeting the aforementioned cut points and 
having a gait speed score of <0.8 m/s.  Of note, the FNIHSP criteria include a more 
conservative grip strength cut point (<16 kg) than the EWGSOP criteria (<20 kg), yet 
both sets of criteria agree on the <0.8 m/s gait speed cut point.  
 Through these three sets of criteria it is evident that the aforementioned 
working groups aimed to create comprehensive screening criteria to identify physical 
function limitations in older adults, rather than separate sarcopenia and dynapenia 
classifications.  This has been argued to be beneficial for clinical assessment as ALM 
alone has not been validated as a clinical measure (Cruz-Jentoft et al., 2010).  Due to 
the variation in cut-points and ALM quantification methods there is no clear 
consensus as to which criteria should be used among different clinical and research 
populations.  Furthermore, some of the current criteria utilize ALM cut points that 
were developed using referent populations from the Rosetta study and the Health ABC 
study.  While these cut-points are methodologically sound they may not be 
representative of all populations, indicating the need for future research to determine 
appropriate lean mass cut points for different populations.  To that end, the use of any 
set of current criteria requires anthropometric, body composition, and physical 
functioning data at the very least.  It is currently unclear which criteria are most 
appropriate for different populations.  If clinical goals are early detection and 
prevention then the EWGSOP criteria may be ideal, as it includes a “pre-sarcopenia” 
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stage, and that criteria has been shown to classify greater percentages of populations 
as sarcopenic than IWG or FNIHSP criteria (Dam et al., 2014).  However the FNIHSP 
criteria has been shown to classify a greater percentage of obese participants as “weak 
with low lean mass” than other criteria, suggesting the adjustment of ALM by BMI 
may be an ideal method of classifying sarcopenia in overweight and obese populations 
(Dam et al., 2014).  Without clear consensus, the classification criteria used may 
depend on the population being assessed.  Researchers and clinicians seeking early 
detection of sarcopenia should use the EWGSOP criteria in populations with healthy 
BMIs, and apply FNIHSP criteria in overweight and/or obese populations.  This 
variation in sarcopenia classification depending on the criteria used and the BMI of 
participants indicates the need for population specific classification criteria to 
effectively identify this condition.   
Treatment for Sarcopenia   
 There are several treatment approaches available for sarcopenia.  Treatments 
should focus around methods of maintaining or improving lean mass, physical 
functioning, and strength levels.  The most common treatment methods include 
hormonal therapies, diet and supplementation approaches, physical activity, and RT.   
Hormonal Treatments 
 Hormonal treatments for sarcopenia have been researched in males and 
females (Borst et al., 2014; Rossouw et al., 2002).  The two most common therapies 
are testosterone and estrogen for males and females respectively.  While some 
research indicates potential side effects, the market for testosterone replacement 
therapy is flourishing and it should be considered as a viable treatment option for older 
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men with sarcopenia.  The most common hormonal replacement therapy (HRT) for 
older women is estrogen and/or estradiol replacement therapy.  While the research 
regarding HRT is encouraging, it remains inconclusive.  Indeed some studies have 
reported negative side effects of HRT in women and that some women discontinued 
prescriptions due to side effects (Bjorn & Backsrom, 1999; Manson et al., 2003).  
However, other studies have shown considerably beneficial effects of HRT in women 
including increases in lean body mass and reduction of risk for coronary heart disease 
(Grodstein, Manson, & Stampfer, 2006; Sorensen et al., 2001).  Overall, HRT in 
women presents a potentially viable treatment method for sarcopenia in women, but 
more research is needed to determine potential side effects and the impacts they may 
have on older women.  
 
 Diet and Supplementation 
 Currently there is encouraging evidence regarding dietary protein intake as 
well as supplementation for lean mass maintenance in older men and women 
(Katsanos et al., 2008; Paddon-Jones & Leidy, 2014).  Several studies have suggested 
that daily intakes of 1.0–1.6 grams of protein per kilogram of body mass is necessary 
for maintenance of muscle mass in older adults (Bauer et al., 2013; Lancha Jr, Zanella 
Jr, Tanabe, Andriamihaja, & Blachier, 2016).  However, some literature suggests that 
high dietary protein intake may lead to potential colon health issues and high protein 
diets may also be contraindicated in those with renal disease and Parkinson’s disease 
(Fracasso, Morais, Gomez, Hilbig, & Rabito, 2013; Russell et al., 2011; Zeller, 
Whittaker, Sullivan, Raskin, & Jacobson, 1991).  Supplementation research also 
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presents a promising avenue for treatment of sarcopenia and is commonly paired with 
resistance training to assess the effects of supplements alone and combined with RT.  
Studies that have examined the effects of creatine supplementation and protein 
supplementation, with and without RT have shown that when combined, 
supplementation and RT provide significant increases in lean mass, strength, and 
physical function in samples of older women (Francis et al., 2016; Gualano et al., 
2014).  However, Francis et al. (2016) did not measure or control for dietary protein 
intake and it is unclear if higher dietary protein intake may have affected those results.  
Additionally, Gualano et al. (2014) conducted their study in older women with 
osteopenia and osteoporosis.  While that was an older population, it is unclear if those 
benefits could be observed in women with sarcopenia.  Therefore, dietary and 
supplementation approaches may treat sarcopenia and attenuate some of the decline in 
lean mass, more research is needed to assess potential side effects and ideal dosage 
strategies for older women with sarcopenia.  
  
Physical Activity  
  Physical activity, often defined as aerobic exercise, has been shown to be 
excellent for overall health and wellbeing as well as preventing and treating other 
chronic diseases (Bonaiuti et al., 2002; Hirose, Hamajima, Takezaki, Miura, & 
Tajima, 2003; Thompson et al., 2003).  Physical activity has also been shown to have 
positive effects on balance and reduction of fall risk in older adults (Buchner et al., 
1997; Gregg, Pereira, & Caspersen, 2000).  Despite those positive health benefits, 
evidence has shown that physical activity alone has little effect on muscular strength 
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or mass.  Some studies have found older adults to increase both strength and lean mass 
following aerobic exercise (Harber et al., 2009; Konopka et al., 2010).  However those 
studies had very small sample sizes and the aerobic training groups were not compared 
to other methods of training.  Additionally, those studies were not conducted in a 
sarcopenic population, and therefore have very limited applicability.  Furthermore, in 
a longitudinal study with five years of follow up, Marcell et al. (2014) found that 35 
active, older women who participated in regular endurance exercise experienced 
significant decreases in strength, while maintaining baseline levels of lean mass.  
Those results indicate that regular endurance exercise may help attenuate the loss of 
lean mass, yet do not prevent the age related loss of strength, which is included in 
sarcopenia classification criteria and associated with functional limitations.  
 Additionally, a study by Mason et al. (2013) examined the effects of diet, 
exercise, and diet and exercise combined on sarcopenia in 439 overweight and obese 
post-menopausal women over a 12-month study duration.  The exercise group 
completed moderate to vigorous aerobic exercise five days per week for 45 minutes 
per session, and consisted of a combination of home and clinic based exercise.  The 
diet intervention group set a weight loss goal of 10% of the baseline weight.  
Sarcopenia was classified using the SMI method developed by Baumgartner (1998) 
and cut points utilized by IWG criteria.  However there was no measurement of gait 
speed, which is a component of IWG criteria.  Post-intervention the exercise group 
experienced a small yet significant 0.4% increase in SMI (p=0.004) compared to the 
control group.  In contrast, the diet group experienced a significant (p=0.01) 3.2% 
decrease in SMI, while the diet and exercise combined group did not significantly 
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change their SMI.  That study indicates that regular aerobic exercise can attenuate the 
loss of lean mass with or without a weight loss intervention.  However those results 
are limited by the lack of physical function assessment, and thus the effects of that 
intervention are inconclusive, as incomplete data prevented pre and post intervention 
sarcopenia classification by current criteria.  Therefore, while beneficial for overall 
health, and potential lean mass maintenance, physical activity (aerobic exercise) does 
not appear to be a viable method of increasing muscle mass or strength; and altering 
sarcopenia classification.   
 
Resistance Training  
 Resistance training (RT) is structured, voluntary movements performed while 
under an external load or resistance (Cholewa et al., 2014).  Resistance training can be 
conducted through a variety of modalities including free weights (Schick et al., 2010), 
selectorized equipment (Fleck & Kraemer, 2014), pneumatic resistance (Frost, 
Bronson, Cronin, & Newton, 2016), and elastic band resistance (Delshad, Ghanbarian, 
Mehrabi, Sarvghadi, & Ebrahim, 2013; Kwak, Kim, & Lee, 2016).  The positive 
effects of RT on strength, lean mass, physical functioning, and gait speed have been 
documented in male and female populations of various ages (American College of 
Sports Medicine, 2009; Fiatarone et al., 1994; Kraemer et al., 2004; Newton et al., 
2002).  Therefore, due to its established benefits, RT merits further investigation as a 
potential treatment for sarcopenia.  
 Examining the effects of RT in older adults was a meta-analysis by Peterson et 
al. (2010).  That analysis used 47 studies with a total of 1079 male and female subjects 
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aged 50-92 years.  The average study duration in that analysis was 17.6 weeks and 
subjects trained from one to three times per week.  The intensity of training as well as 
volume (sets and repetitions) of exercises varied between studies, although most 
included measures of maximal leg press and/or chest press strength in their results.  
Those researchers found upper and lower body strength measured by chest and leg 
press to increase by 24% and 29% respectively.  However, those results are from 
combined pool estimates of strength, and the studies included had large variation in 
training program design and participants.  Nonetheless, those results indicate that both 
upper and lower body strength are responsive to RT in older adults. 
 A further meta-analysis by Peterson & Gordon (2011) included 49 studies and 
1,328 male and female participants with a mean age of 65.5 years.  Study duration 
ranged from 10 to 52 weeks and resistance-training programs included community-
based programs, in home programs, and individual personal training programs.  A 
weighted pooled estimate found a mean lean mass increase of 1.1 kg over a mean 
study duration of 20.5 weeks.  Those results are encouraging and demonstrate the 
ability of older adults to experience muscular hypertrophy with RT.  However, the 
variation in programming style and study duration may limit the applicability of these 
results and limit use in intervention design.  Nonetheless, that study indicates that 
despite large variations in program design and training duration, older adults can 
experience increases in lean mass with RT.  However information regarding ideal RT 
program design to increase lean mass in older adults is needed to apply these findings 
in a clinical setting.  
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 Although results from Peterson & Gordon (2011) indicate significant increases 
in lean mass following 20.5 weeks of training, other research has found similar results 
in shorter durations.  Delmonico et al. (2005) implemented a 10-week RT program in 
a cohort of 62 previously inactive older men and women.  Participants trained three 
days per week and completed five sets of unilateral knee extensions on the dominant 
leg.  This allowed for the non-dominant leg to act as a control.  Those researchers 
found that following 10 weeks of RT significant increases in muscle volume were seen 
in men (165 cm3) and women (93 cm3) when compared to baseline measures 
(p<0.001).  Those data suggest that it is possible for older adults to experience 
significant increases in muscle volume following 10 weeks of regular RT.  While 
those results are positive unilateral training of only one movement on one leg may 
limit the applicability of that study.  Indeed structured RT programs typically include 
multiple exercises, often bilateral, to target the entire body (American College of 
Sports Medicine, 2009). 
 Gait speed is also responsive to resistance training.  A study conducted by 
Fiatarone et al. (1994) included 90 older men and women aged 87±0.6 years who were 
randomized into four groups: exercise, exercise and supplement, supplement placebo, 
and control.  The exercise group completed movements that trained the hip and knee 
extensors three days per week for 10 weeks.  The exercise group experienced a 
significant 8.6% (p=0.009) increase in gait speed when compared to the inactive 
groups.  Also of note, both the exercise and exercise plus supplement groups 
experienced significant increases in hip and knee strength (p<0.001).  That study, 
while conducted in older adults, took place in 1994 prior to the development of current 
 53  
sarcopenia classification criteria.  Therefore it is unclear if the participants were 
sarcopenic or had symptoms of sarcopenia (low gait speed, low strength, low ALM).  
However it is evident that RT can positively influence gait speed in older adults.  
 Also supporting the use of resistance training to improve gait speed was a 
recent study by Santos et al. (2017), who delivered an 8-week RT intervention to 23 
healthy older women aged 69.6±6.4 years.  Participants trained three days per week 
following a program designed to meet ACSM recommendations for muscle 
hypertrophy and strength.  Following the training program participants’ gait speed 
improved by 3.67% (p=0.03).  Those results indicate that RT can result in significant 
improvements in gait speed time in older women.  However that study used a 10-meter 
fast walking speed test, which may not be indicative of normal gait speed in older 
adults.  Additionally, although the women included in that study were older and 
inactive, they were not evaluated for sarcopenia and it is unknown if similar results 
can be observed in older sarcopenic women.  
 Recent research has also compared the effects of aerobic and resistance 
training on strength in 93 older men and women.  Participants aged 65-75 years, with 
sarcopenic obesity were randomized to four groups: aerobic training, resistance 
training, combined aerobic and resistance training, and a control group.  Training 
groups trained two times per week for eight weeks and underwent post-intervention 
testing, and follow-up testing four weeks post intervention.  Results indicated that the 
RT group experienced significant gains in grip strength (3.5 kg, p<0.05) that were 
maintained four weeks post intervention compared to all other groups (Chen, Chung, 
Chen, Ho, & Wu, 2017).  Those results indicate that one-day of RT per week will not 
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produce significant gains in grip strength, and that greater frequencies of RT are 
needed to increase grip strength.  Moreover, that study further demonstrated the 
shortcomings of aerobic exercise at treating symptoms of sarcopenia.  Additionally, 
although the participants in that study were assessed for sarcopenia at baseline there 
was no discussion regarding change in sarcopenia status post intervention.  
Nonetheless, grip strength is included in current sarcopenia classification criteria, and 
that study demonstrated that RT is the most effective method of increasing grip 
strength in that population compared to other exercise modalities. 
 
 Further demonstrating the efficacy of RT as a treatment for sarcopenia was a 
recent study by Stoever et al. (2015).  Those researchers investigated the effects of RT 
on 18 obese, older men with sarcopenia and 15 obese, older men without sarcopenia.  
Sarcopenia was classified using the SMI method and participants completed a RT 
program two days per week for 16 weeks.  Following the program the participants 
with sarcopenia had increased their grip strength by 12% and the non-sarcopenic 
participants maintained their baseline levels of strength.  That study indicates that RT 
is effective at attenuating the age related loss of grip strength in non-sarcopenic men 
and improving grip strength in men with sarcopenia.  Similar effects were seen in 
women in a study by Rhodes et al. (2000), who found 20 older women to increase grip 
strength by 8% following one year of RT.  However, that study was conducted in 
women without sarcopenia and it is unclear if those results can be duplicated in older 
women with sarcopenia.  
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 While many RT studies vary in frequency, the most common frequency is 
three days per week.  Farinatti et al. (2013) investigated the effects of different 
frequencies of RT on measures of strength and functional performance in 48 women 
over the age of 60.  Participants were randomized to a control group or one of three 
training groups that trained one, two, or three days per week.  Participants then 
completed a 16-week, single set RT program.  Post intervention all three training 
groups experienced significant increases in strength compared to baseline measures 
and the control group.  However, the training group that met three days per week 
experienced the greatest increase in overall gait speed, which was significantly greater 
than the other two training groups and the control group.  The training group that met 
three days per week also experienced significant decreases in chair sit and stand time 
when compared to the group that trained 1 day per week.  That study indicates that in 
older, untrained women lower frequency RT may provide enough of a stimulus to see 
initial increases in strength, but in order to see the greatest improvements in functional 
performance older women should train three days per week.  Of particular interest is 
the vast improvements in the gait speed times for the three day per week training 
group (-11.6%) compared to the two day per week training group (-5.1%).  
 Considering that gait speed is a component of current sarcopenia classification 
criteria and an important functional measure, future RT interventions should seek to 
program training three days per week in order to realize the greatest improvements in 
gait speed.  Furthermore, that study incorporated a single set RT program, which has 
been shown to be inferior to multiple set RT programs for strength improvements (W. 
K. Kemmler, Lauber, Engelke, & Weineck, 2004).  Therefore, in order for older 
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women to experience maximum improvements in strength and functional performance 
they should partake in a multiple set RT program three days per week.  
 
Periodized Resistance Training 
 The aforementioned studies demonstrate the efficacy of RT in treating 
symptoms of sarcopenia and utilized what is considered conventional RT.  
Conventional RT is commonly programmed using the progressive overload principle, 
which involves gradually increasing training workload (Hass, Feigenbaum, & 
Franklin, 2001).  Conventional RT programs, especially those in older individuals are 
typically structured using baseline strength measures, and progressively increase the 
intensity of the movements for the duration of intervention (Farinatti et al., 2013; Ferri 
et al., 2003; Krist, Dimeo, & Keil, 2013).  In programs of that style, the number of sets 
and repetitions is often held constant (fixed volume), and the only variations in the 
training program are increases in intensity when appropriate (Pollock, Graves, Swart, 
& Lowenthal, 1994).  Other variations of conventional RT include programs where 
participants only complete one set of prescribed exercises per training session (single 
set) (Wolfe, LeMura, & Cole, 2004).  These types of design limit the ability of the 
participants to obtain maximum benefits from a RT program, as different intensities 
and repetition ranges can be used to target muscular strength, hypertrophy, endurance, 
and power (Haff & Triplett, 2015).  
 A different method of designing RT programs is periodization.  Periodized 
resistance training (PRT) programs use pre-planned variations of acute training 
program variables.  The program variables that are modified are exercise selection, 
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exercise order, intensity, volume, and rest periods (Bartolomei, Stout, Fukuda, 
Hoffman, & Merni, 2015; Haff & Triplett, 2015).  There are many different methods 
of designing PRT programs and few studies incorporate identical training programs, 
which limits the comparison of results within the literature.  While conventional RT 
can certainly be beneficial for many populations, multiple studies have demonstrated 
the benefits of PRT over conventional RT (Fleck, 1999; Rhea & Alderman, 2004).
 A meta-analysis by Rhea and Alderman (2004) compared the effects of 
conventional RT and PRT on strength and power outcomes.  Those researchers 
conducted two separate analyses using the effect sizes of available research and found 
PRT to have a significantly greater effect size (ES=0.84) for both strength and power 
outcomes when compared with conventional RT.  Those researchers also found that 
when studies were equated for volume intensity that PRT still elicited greater training 
responses than conventional PRT.  
 Periodized resistance training can be broken down into linear and non-linear 
periodization.  Linear PRT programs are oft characterized by progressive decreases in 
training volume (sets and repetitions) and increases in intensity (load or weight lifted) 
between cycles (Conlon et al., 2016).  The most common form of linear periodization 
is block periodization, which was first introduced in the 1970s by Verkhoshansky, 
who designed programs for track and field athletes (Yessis, 1982).  Block 
periodization is commonly programmed using four-week training segments, called 
mesocycles.  Each mesocycle targets a single training outcome variable or adaptation 
(i.e., muscular hypertrophy, strength, or power).  Athletes seeking peak performance 
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for individual competitions or competitive seasons often use linear/block PRT 
programs (Turner, 2011).  
 In a study by Botero et al. (2013), 23 post-menopausal women followed a 
linear PRT program two days per week for 12 months.  Participants were inactive 
prior to study inclusion and followed a traditional linear model of periodization: 
progressive increases in intensity, and decreases in volume.  Following intervention 
participants displayed significant increases in bench press (30.82%, p<0.05) and leg 
press (100.9%, p<0.05).  Participants also displayed significant increases in lean mass 
(1.59%, p=0.009).  That study supports the use of PRT; especially linear PRT due to 
the significant increases in strength and lean mass experienced by the participants.  
However, that study did not include secondary test groups investigating other forms of 
RT in comparison to the PRT program or a control group. Additionally, due to the 
linear program design, participants had completed a strength cycle of training just 
prior to post-intervention testing, which may have influenced the final results.  
Furthermore, that study claimed that long-term PRT prevents sarcopenia, which is a 
bold claim, however there is no indication that these researchers assessed sarcopenia 
by any criteria.  While that study produced positive results, it suggests further research 
is needed investigating forms of PRT in post-menopausal women who have been 
screened for sarcopenia.  Additionally, linear PRT programs, while beneficial for 
individuals of all sexes and ages, may not be ideal for those who are not training for a 
specific event or season, but rather seeking to improve and maintain strength, lean 
mass, and physical functioning, like older adults (Kraemer et al., 2004; Miranda et al., 
2011). 
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 Non-linear periodization still incorporates modifications of program variables 
similar to linear/block PRT programs, however non-linear PRT can be programmed so 
that participants train for separate outcomes (hypertrophy, strength, or endurance) on a 
daily or weekly basis, rather than a bi-weekly or monthly basis.  This may be 
beneficial for those seeking a well-rounded training program that allows for 
continuous training of multiple outcomes.  While there are not any set rules or 
guidelines one must follow to design non-linear PRT programs, a common method is 
weekly or daily undulations.  The undulations signify modifications to program 
variables (exercise selection, order, intensity, volume, and rest periods).  Individuals 
following weekly undulating PRT (WUP) programs will commonly train for a specific 
adaptation (i.e. strength) for one week, then train for a different adaptation (i.e. 
hypertrophy) the following week.  Daily undulating PRT (DUP) programs simply 
incorporate modifications of training variables and targeted adaptation on a daily 
basis.  These undulations are designed to provide periods of low intensity training, 
which allow adaptations to occur, decrease the risk of overtraining, and maintain 
interest in the program (Komi, 1986; Rhea & Alderman, 2004).  
 Indeed, research shows that consistently high training intensities contribute to 
increased inflammatory markers and symptoms of delayed onset muscle soreness 
(Hasenoehrl et al., 2016; Nosaka, Newton, & Sacco, 2002).  Additionally, in a joint 
consensus statement, the European College of Sport Science and the American 
College of Sports Medicine suggested that adjusting daily training intensities and 
volumes and/or allowing rest days is vital to preventing overtraining (Meeusen et al., 
2013).  Those organizations also recommended avoiding monotonous training 
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programs and that one of the best methods of preventing overtraining syndrome is 
appropriately periodizing training programs and allowing adequate time for rest and 
recovery (Meeusen et al., 2006).  Therefore a DUP program would provide the 
variations required to prevent excessive soreness, overtraining, and boredom, all of 
which may promote adherence to a training program.  
 There is much debate within the literature regarding ideal RT program design 
for different populations, and researchers have compared linear PRT and non-linear 
PRT programs.  A recent meta-analysis by Harries et al. (2015) compared the effects 
of linear and undulating PRT on strength measures.  That analysis of 17 studies 
including 510 participants found no significant differences between linear or 
undulating programs on strength.  However that study acknowledged that many of the 
studies in the meta-analysis included participants that were previously trained and that 
the short duration of the included studies may have confounded the results.  
Furthermore, no study included in that analysis included participants over the age 65, 
with participants’ ages ranging from 19-39 years.  Due to the potential confounding 
variables and relatively young study populations, those results may not be applicable 
to older, untrained adults with functional limitations.  
 Conversely, a study by Bartolomei et al. (2015) randomized 17 trained women 
aged 24.7±4.2 years to either a block periodization group or a WUP group.  Both 
programs were equated for volume and both groups trained three days per week for 10 
weeks.  Post training, results indicated that both groups significantly increased 
strength, but the WUP group experienced significantly greater improvements in lower 
body strength (p=0.039) when compared to the block-periodized group.  Furthermore, 
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the WUP group experienced significant increases in thigh cross sectional area 
(p=0.001) when compared to the block-periodized group.  Those results indicate that a 
WUP program may be superior to block periodization for improving strength and lean 
mass in women.  However, that study included young, trained women and results may 
have limited applicability in older adults, especially those with sarcopenia.  
Nonetheless, those results suggest that non-linear PRT is superior to linear PRT for 
strength and mass gains in women.  
 There have also been comparisons between linear PRT and non-linear DUP 
programs.  One study compared those two program designs in 20 college-aged men 
over the course of 12 weeks.  Both groups trained three days per week and both 
programs were equated for volume.  Following training, both groups significantly 
increased their strength from baseline values.  However the DUP group experienced a 
28.8% increase in bench press strength, and a 55.8% increase in leg press strength 
from baseline values.  Those increases were significantly greater than the linear PRT 
group, which experienced a 14.4% increase in bench press strength, and a 25.7% 
increase in leg press strength (Rhea, Ball, Phillips, & Burkett, 2002).  
 Similar results were observed by Prestes et al. (2009), who compared 12 weeks 
of linear PRT and DUP in 40 trained, college-aged men.  Participants trained four 
times per week, and following 12 weeks both groups significantly increased bench 
press and leg press strength, however the DUP group displayed significantly higher 
increases than the linear PRT group for both bench press (p=0.002) and leg press 
(p=0.001).  However the studies by both Rhea et al. (2002) and Prestes et al. (2009) 
included college-aged men, and despite the potential benefits of DUP in older women, 
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a search of the literature indicated that the effects of DUP have not been investigated 
in postmenopausal women with sarcopenia.  
 Although the available research regarding RT and PRT in women 
demonstrates the clear potential for increases in strength, mass, and physical function, 
no research is available regarding PRT, particularly DUP in women with sarcopenia.  
Due to the potential for greater increases in strength and other performance measures, 
as well as the potential for greater program adherence, DUP appears to have the 
potential to be an effective method of treating sarcopenia in older women, yet remains 
uninvestigated.  Reasons for this lack of research are unclear and the feasibility of 
administering a DUP intervention to older women with sarcopenia remains to be seen.  
To date no study has investigated the effects of DUP on women with sarcopenia and it 
is unclear if this type of training would provide sufficient gains in lean mass, strength, 
and/or physical functioning to alter sarcopenia classification based on current criteria.  
 
Conclusion 
 Based on the current literature, sarcopenia presents a growing public health 
issue with the potential to negatively affect the physical functioning and overall health 
levels of older adults, especially women.  Due to lack of consensus among 
classification criteria, researchers may benefit from using the three most prominent 
sets of current criteria to classify sarcopenia as it would allow for greater overall 
assessment of sarcopenia and more direct comparison of results from other studies.  
Considering the lack of side effects and clearly established benefits on sarcopenia 
classification measures, RT appears to be the most valid method of treating sarcopenia 
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in older adults.  Furthermore, research suggests that DUP provides greater increases in 
performance when compared to conventional RT and has not been researched in older 
women with sarcopenia.  It is unclear if a DUP intervention would provide necessary 
increases in performance measures to alter sarcopenia classification by current criteria.  
Therefore, future research should seek to investigate the effects of DUP on sarcopenia 
classification in older postmenopausal women with sarcopenia. 
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Appendix B: Phone Screen Assessment  
URI Resistance Exercise Study to Reclaim Lean Muscle and Strength (URI 
RESTORE ME Project) 
Data Sheet for Detailed Subject Telephone Interview 
 
❏ Brief Explanation of Study 
❏ Permission to Conduct Interview?      ______Yes   _______No    
 
Comment:___________________________________________________________ 
 
Name:  Dr./Ms./Mrs.________________________________________________ 
Address: ________________________________________________________ 
     ________________________________________________________ 
Phone #:_________________________________________________________ 
E-Mail:___________________________________________________________ 
Best Way and Time to Contact:________________________________________ 
 
• Time Commitment – Available 
   ____Yes    ____No       Wants to be contacted after ________ (Date) 
Comment:___________________________________________________________
_______ 
• Proximity to URI 
Length of commute: ______ miles  or  ______ minutes 
Within reasonable commute_____       Willing to make unreasonable 
commute______ 
Too far to commute______ 
 
• Age 
Age: _____ yrs  Date of Birth:  _____/_____/_____ 
          MM   DD  YY 
 
Approximate Height:  ___________ Approximate Weight: ___________  BMI: 
____________ 
 
• Race 
  ___ American Indian or Alaskan Native 
 ___ Asian or Pacific Islander 
   ___ Black, not of Hispanic origin 
   ___ Hispanic 
   ___ White, not of Hispanic origin 
   ___ Other/Unknown 
   
• Highest level of education completed 
 ___ Less than high school 
 ___ High school or GED 
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 ___ Some college 
 ___ Two-year college degree (e.g. Associates) 
 ___ Four-year college degree (e.g. B.S., B.A.) 
 ___ Masters degree 
 ___ Doctoral degree 
 ___ Professional degree (e.g. M.D., J.D.) 
 ___ Other (please specify) ________________________________________ 
 
• Have you attained menopause?  Yes ______ No_______ 
If Yes, for how long? _____________________ 
• Smoking  
Always Non-Smoker_______    Non-Smoker for ___________    
Smoker________ 
 
 
• Physical Activity 
      Participates in regular (>1x/wk for past 3 months) exercise?      ____Yes     
_____No  
     If yes, describe in detail (e.g. frequency, intensity, duration, mode) 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
_____________________________________________ 
     Describe other non-structured physical activity (e.g. leisure time, gardening, 
occupational, or other) 
____________________________________________________________________
____________________________________________________________________
______________________________ 
• Cardiovascular (heart, blood, or blood vessel) conditions? 
____No    ____Yes (Record on Medical History/Treatment Form) 
Comments:_____________________________________________________
 ______________________________________________________________ 
 
• Respiratory Conditions? 
____No    ____Yes (Record on Medical History/Treatment Form) 
Comments:_____________________________________________________
_
 ______________________________________________________________
_ 
 
• Osteoarthritis/Degenerative Arthritis 
 ___No     ___Yes 
 80  
If yes, how long and what was the 
severity______________________________ 
______________________________________________________________
__ 
 
• High Blood Pressure 
  No_____  
Yes_____ Controlled (Record High BP and Treatment on Medical 
History/Treatment Form)  
Yes_____ Uncontrolled 
Comments:________________________________________________________
_________________________________________________________________
______________________________ 
 
• Orthopedic conditions (knee, neck, or other back pain) 
___No      ___Yes 
If yes, describe in detail including severity 
______________________________________________________________
______________________________________________________________
______________________________ 
 
• Diabetes 
 _____No  
_____Yes – Type 2. If type 2, taking insulin now? 
_______________________ 
_____Yes – Type 1 (Insulin Dependent) 
 Comments:_____________________________________________________
_       
            
________________________________________________________________ 
 
 
 
• Any major surgeries as an adult? 
___No      ___Yes 
If yes, what type (e.g. surgeries of the joints, heart surgeries, angioplasty, 
bypass surgery, pacemakers, etc.) and date(s) 
______________________________________________________________
______________________________________________________________
______________________________________________________________
_____________________________________________ 
 
• Other Medical Conditions (especially those that would make exercise difficult 
or unsafe) 
 _____No  
_____Yes (Record on Medical History/Treatment Form)  
 Comments:_____________________________________________________
______________       
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____________________________________________________________________
________ 
 
• Medication Info – See last page 
 _____No  
_____Yes (Record on Medical History/Treatment Form)  
 Comments:_____________________________________________________
______________       
            
____________________________________________________________________ 
 
• Personal Physician Info 
 Name of Physician:  
______________________________________________________ 
 Specialty of Physician: 
____________________________________________________ 
 Phone 
Number:__________________________________________________________ 
 Fax Number: 
____________________________________________________________ 
 Address (if phone and fax unknown): 
________________________________________ 
 ______________________________________________________________
________ 
 ______________________________________________________________
________  
 
• Summary 
Interviewer Printed Name: ______________________________________ 
        
Interviewer Signature:       ______________________________________ 
 
 Questions/ 
Comments:_______________________________________________________ 
 ______________________________________________________________
___________ 
Reviewer Initials: ______  
 
 _____Appears to Qualify      _____Need 
More Information  
_____Needs Drs. Delmonico, Hatfield, Xu, or Lofgren to review  _____ Not 
Qualified 
  
Questions/ 
Comments:___________________________________________________________ 
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Appendix C: Consent Form for Research 
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Appendix D: Pre-participation Medical Clearance  
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Appendix E: Medical History Questionnaire  
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Appendix F: Baseline Data Collection Sheet 
 
64 
 
Appendix E. Baseline Data Collection Sheet 
 
 
 
 
 
URI RESTORE ME Study Data Sheet 
 
BaselineTesting Day 1 
Participant ID #:    Date: 
 
 
 
 
 
 
 
Measurements Baseline Testing Day 1 Initial 
Resting Heart Rate 1 (bpm)   
Resting Heart Rate 2 (bpm)   
Resting Blood Pressure 1   
Resting Blood Pressure 2   
 
Grip Strength (kilograms)  
Dynamometer Setting: Best Grip Trial: 
Grip R1: Grip R2: Grip L1: Grip L2: 
 
 96  
 
65 
 
Baseline Testing Day 1      
Participant ID#:    Date: 
 
SPPB 
BALANCE SCORING: 
  A. Side-by-side-stand 
o Held for 10 sec   1 point  
o Not held for 10 sec   0 points  
o Number of seconds held if less than 10 sec:____sec 
o Not attempted   0 points 
o If participant did not attempt test or failed, check why: 
o Participant could not walk unassisted   
o Not attempted, you felt unsafe   
o Not attempted, participant felt unsafe   
o Participant unable to understand instructions   
o Other (Specify)   
o Participant refused   
o If 0 points, end Balance Tests  
 
  B. Semi-Tandem Stand 
o Held for 10 sec   1 point 
o Not held for 10 sec   0 points 
o Number of seconds held if less than 10 sec:____sec 
o Not attempted   0 points 
o If participant did not attempt test or failed, check why: 
o Participant could not walk unassisted   
o Not attempted, you felt unsafe   
o Not attempted, participant felt unsafe  
o Participant unable to understand instructions   
o Other (Specify)   
o Participant refused   
o If 0 points, end Balance Tests 
  C. Tandem Stand 
o Held for 10 sec   2 points 
o Held for 3 to 9.99 sec   1 point 
o Held for < than 3 sec   0 points 
o Not attempted   0 points  
o If participant did not attempt test or failed, check why: 
o Participant could not walk unassisted   
o Not attempted, you felt unsafe   
o Not attempted, participant felt unsafe   
o Participant unable to understand instructions   
o Other (Specify)   
o Participant refused   
  D. Total Balance Tests score ______(sum points) 
  For 4-Meter Walk:  
o If time is more than 8.70 sec:   1 point  
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o If time is 6.21 to 8.70 sec:   2 points  
o If time is 4.82 to 6.20 sec:   3 points 
o If time is less than 4.82 sec:   4 points 
CHAIR SCORING: 
  Single Chair Stand Test: 
o Safe to stand without help  YES    NO   
o Participant stood without using arms  YES    NO  ÆIf yes go to repeated stand 
o Participant used arms to stand YES   NO  ÆIf yes end test; score as 0 points 
o Test not completed   ÆEnd test; score as 0 points 
o If participant did not attempt test or failed, check why: 
o Tried but unable   
o Participant could not walk unassisted   
o Not attempted, you felt unsafe   
o Not attempted, participant felt unsafe  
o Participant unable to understand instructions   
o Other (Specify)   
o Participant refused   
 
  Repeated Chair Stand Test 
o Safe to stand five times Yes      No   ÆIf five stands completed record time 
o Time to complete five stands ___sec 
o If participant did not attempt test or failed, circle why: 
o Tried but unable   
o Participant could not walk unassisted   
o Not attempted, you felt unsafe   
o Not attempted, participant felt unsafe  
o Participant unable to understand instructions  
o Other (Specify)   
o Participant refused   
 
  Scoring the Repeated Chair Test 
o Participant unable to complete 5 chair stands or completes stands in >60 sec:    
0 points 
o If chair stand time is 16.70 sec or more:    1 points 
o If chair stand time is 13.70 to 16.69 sec:    2 points 
o If chair stand time is 11.20 to 13.69 sec:    3 points 
o If chair stand time is 11.19 sec or less:    4 points 
 
  Scoring for Complete Short Physical Performance Battery 
  Total Balance Test score _____ points 
  Gait Speed Test score _____ points 
  Chair Stand Test score _____ points 
  Total Score _____ points (sum of points above) 
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Test    Result Date Completed Initial 
400m walk 
(sec) 
   
SPPB points scored   
Single Leg 
Stand, 10 sec 
   
Sit and Reach 
(+/- cm) 
   
Timed Up 
and Go 1 
(sec) 
   
Timed Up 
and Go 2 
(sec) 
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Baseline Testing 
Participant ID #:    Date:    
   
Notes: 
 
 
Measurements Date Initial 
Resting Heart Rate 1 (bpm)   
Resting Heart Rate 2 (bpm)   
Resting Blood Pressure 1   
Resting Blood Pressure 2   
Blood Draw 1   
 
Anthropometrics Measurement 
1 
Measurement 
2 
Average Initial 
Height (inches)     
 Weight (lbs)     
Waist 
Circumference 
(inches) 
    
Hip 
Circumference 
(inches) 
    
BMI (kg/m2)  Waist to Hip 
Ratio 
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Baseline Testing  
Participant ID#:    Date:     
 
 Results collected Date   Initial 
DEXA    
 
Measurements Baseline Testing Day 1 Initial 
Resting Heart Rate 1 
(bpm) 
  
Resting Heart Rate 2 
(bpm) 
  
Resting Blood Pressure 
1 
  
Resting Blood Pressure 
2 
  
Blood Draw 2 
 
  
 
In-Body: BIA Date:        
Voided Bladder           Yes   No 
Height: Weight: BMI:  
R Arm LM: L Arm LM: R Leg LM: L Leg LM: 
 Total ALM: 
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Appendix G: One Repetition Max Testing Sheet 
 
 
 
 
RESTORE ME 1RM Testing Data Sheet  (Baseline)                  
Date:                                                       Resting BP__________ 
Subject ID: __________                                 Resting HR__________ 
Tester:______________                                 Dynamic Warm-up Completed__________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Leg Press   
Max Weight Lifted During Familiarization_______________        Seat Position___________ 
                                                                                                                                                                    CR-10 
Warm-Ups: 1.     lbs (5-10 reps @ 50%)  Attempts: 1.     lbs__________ 
         2.     lbs (2-5 reps @ 75%)         2.     lbs__________  
         3.     lbs (1 rep @ 85-90%)          3.     lbs__________ 
                4.     lbs___________ 
                   5.     lbs___________ 
Notes:                
               
               
               
                
 
Chest Press  
Max Weight Lifted During Familiarization_______________          Seat Position___________ 
                                                                                                                                                                    CR-10 
Warm-Ups: 1.     lbs (5-10 reps @ 50%) Attempts: 1.     lbs ________ 
         2.     lbs (2-5 reps @ 75%)        2.     lbs ________ 
         3.     lbs (1 rep @ 85-90%)       3.     lbs_________ 
                 4.     lbs_________ 
                   5.     lbs_________ 
Notes:                
               
               
               
                
               
               
               
                
   
 
 
 
Blood Pressure (after 2-3 mins rest)______________ 
 
Blood Pressure (after 2-3 mins rest)______________ 
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Appendix H: Borg CR-10 Scale and Instructions 
 
Borg CR-10 Scale of Perceived Exertion 
 
 
 
0 Nothing at all  
0.3 
0.5 Extremely weak    Just noticeable 
0.7 
1 Very weak 
1.5 
2 Weak      Light 
2.5 
3 Moderate      
4 
5 Strong      Heavy 
6 
7 Very strong 
8 
9 
10 Extremely strong    “Maximal” 
11 
• Absolute Maximum    Highest possible 
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Instructions:  
 
 While exercising we want you to rate your perception of exertion, i.e., how 
heavy and strenuous the exercise feels to you.  The perception of exertion 
depends mainly on the strain and fatigue in you muscles and on your feeling of 
breathlessness or aches in the chest. 
 Look at this rating scale; we want you to use this scale from 1 to 10, 
where 1 means “no exertion at all” and 10 means “maximal or very, very strong 
exertion.” 
 For most people this is the most strenuous resistance exercise they have 
ever experienced. 
 Try to appraise your feeling of exertion as honestly as possible, without 
thinking about what the actual physical load is.  Don’t underestimate it, but don’t 
overestimate it either.  It’s your own feeling of effort and exertion that’s important, 
not how it compares to other people’s.  What other people think is not important 
either. In addition, this scale has no anchor.  That is, if after giving a “10” on a 
previous rating, you decide that the current exercise is more strenuous, you may 
give a higher number (i.e. “11”0.   Look at the scale and the expressions and 
then give a number. 
 Any questions?  
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Appendix I: Dietary Screening Tool  
 
 
 
 
 
Dietary Screening Tool 
 
 
DIRECTIONS: Please check one response to each question that best describes how 
you eat.  
 
 
How often do you usually eat fruit as a snack? 
____ Never  
____ Less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you usually eat whole grain breads? 
____  Never or less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you usually eat whole grain cereals? 
____  Never or less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you usually eat candy or chocolate? 
____  Never  
____ Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat crackers, pretzels, chips, or popcorn? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat cakes or pies? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
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How often do you eat cookies? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
 
How often do you eat ice cream? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat cold cuts, hot dogs, lunchmeats or deli meats? 
____ Never  or less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat bacon or sausage? 
____ Never  or less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat carrots, sweet potatoes, broccoli, or spinach? 
____ Never  
____ Less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat fruit (not including juice)? Please include fresh, 
canned or frozen fruit. 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
  
  
How often do you eat hot or cold breakfast cereal? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____ 3 to 5 times a week 
____  Every day or almost every day  
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How often do you drink some kind of juice at breakfast? 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
 
How often do you eat chicken or turkey? 
____ Never or less than once a week 
____ 1 or 2 times a week 
____ More than 3 times a week 
 
 
How often do you drink a glass of milk? 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
____ More than once every day 
 
 
Do you usually add butter or margarine to foods like bread, rolls, or 
biscuits? 
____ Yes   
____ No 
 
Do you usually add fat (butter, margarine or oil) to potatoes and other 
vegetables? 
____ Yes   
____ No 
 
Do you use gravy (when available) at meals? 
____ Yes   
____ No 
 
Do you usually add sugar or honey to sweeten your coffee or tea? 
____ Yes   
____ No 
  
 
Do you usually drink wine, beer or other alcoholic beverages? 
____ Yes   
____ No 
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How often do you eat fish or seafood that IS NOT fried? 
____ Never  
____ Less than once a week 
____ Once a week 
____ More than once a week  
 
How many servings of milk, cheese, or yogurt do you usually have 
each DAY? 
____ None  
____ One  
____ Two or more  
 
How many different vegetable servings do you usually have at your 
main meal of the day?  
____ None  
____ One  
____ Two  
____ Three or more 
 
 
Which of the following best describes your nutritional supplement 
use. 
____  I don’t use supplements  
____  I use supplements other than vitamins and mineral 
____  I use a multivitamin/mineral preparation (e.g. Centrum) 
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Appendix J: One-Week Training Program for Daily Undulating Periodization Group  
